<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Trends Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Trends Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Trends in immunology</journal-title></journal-title-group><issn pub-type="ppub">1471-4906</issn><issn pub-type="epub">1471-4981</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12476025</article-id><article-id pub-id-type="pmcid-ver">PMC12476025.1</article-id><article-id pub-id-type="pmcaid">12476025</article-id><article-id pub-id-type="pmcaiid">12476025</article-id><article-id pub-id-type="manuscript-id">NIHMS2100613</article-id><article-id pub-id-type="pmid">40849263</article-id><article-id pub-id-type="doi">10.1016/j.it.2025.07.014</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2100613</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2100613</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Mitochondria and lysosomes in T cell immunometabolism</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Norton</surname><given-names initials="EG">Erienne G.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chapman</surname><given-names initials="NM">Nicole M.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9997-2496</contrib-id><name name-style="western"><surname>Chi</surname><given-names initials="H">Hongbo</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Immunology, St. Jude Children&#8217;s Research Hospital, Memphis, TN, USA</aff><aff id="A2"><label>2</label>St. Jude Graduate School of Biomedical Sciences, St. Jude Children&#8217;s Research Hospital, Memphis, TN, USA</aff><author-notes><corresp id="CR1"><label>*</label>Correspondence: <email>hongbo.chi@stjude.org</email> (H. Chi).</corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>22</day><month>8</month><year>2025</year></pub-date><volume>46</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">497680</issue-id><fpage>635</fpage><lpage>651</lpage><pub-history><event event-type="nihms-submitted"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-release"><date><day>27</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 21:25:17.150"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2100613.pdf"/><abstract id="ABS1"><p id="P1">Metabolic reprogramming and signaling are key orchestrators of T cell immunity. Recent studies have illustrated important roles for intracellular organelles, especially mitochondria and lysosomes, in enforcing T cell metabolism and signaling in response to various extracellular cues. As such, mitochondrial and lysosomal function contributes to adaptive immunity by regulating T cell activation, differentiation, and functional adaptation. In this Review, we discuss how the interplay between organelle biology and metabolism instructs T cell-mediated immunity, with a particular focus on mitochondria and lysosomes. We also summarize how mitochondria and lysosomes, or their crosstalk with other organelles, orchestrate downstream signaling processes and functional reprogramming of T cells. We conclude with a discussion of the pathophysiological outcomes associated with dysregulation of these organelles.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="S1"><title>Mitochondria and lysosomes are metabolic hubs in T cells</title><p id="P2">T cells are an essential component of adaptive immunity, necessary for defense against pathogens and cancer. Conventional &#945;&#946; T cells are comprised of two major subsets: CD4<sup>+</sup> T cells that use specific effector functions to combat intracellular or extracellular pathogens or support the activation of humoral responses; and CD8<sup>+</sup> T cells that eliminate pathogens or malignant cells via cytokine secretion or release of cytotoxic granules [<xref rid="R1" ref-type="bibr">1</xref>]. A CD4<sup>+</sup> T cell subpopulation called regulatory T cells (Tregs) exerts immune suppressive function to circumvent T cell-mediated autoimmunity or immunopathology [<xref rid="R1" ref-type="bibr">1</xref>]. In the thymus and periphery, T cells receive multiple instructive signals that underlie their development, activation, and differentiation [<xref rid="R1" ref-type="bibr">1</xref>]. Among them, cellular metabolism and nutrient uptake, together with metabolic signaling events, are crucial regulators of T cell biology [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref>]. Therefore, discovering the driver signals and mechanisms of T cell <bold>immunometabolism</bold> (see Glossary) holds therapeutic potential for improving disease outcomes related to infection, autoimmunity, or cancer.</p><p id="P3">Intracellular organelles, especially mitochondria and lysosomes, orchestrate metabolic rewiring in T cells. Mitochondria facilitate oxidative metabolism for energy (ATP) production and generation of biosynthetic intermediates, including those essential for nucleotide and lipid synthesis. Moreover, mitochondria play critical roles in redox balance and serve as a central node for crosstalk between the endoplasmic reticulum, nucleus, and peroxisomes, thereby impacting T cell metabolism [<xref rid="R3" ref-type="bibr">3</xref>]. The bioenergetic and biosynthetic functions of mitochondria are instructed by signaling and nutrient cues that tune mitochondrial biogenesis and turnover, as well as mitochondrial dynamics [<xref rid="R4" ref-type="bibr">4</xref>]. Lysosomes mediate macromolecule recycling and clearance of damaged organelles, which support energetic needs during nutrient stress to maintain cellular fitness [<xref rid="R5" ref-type="bibr">5</xref>]. To facilitate these functions, lysosomes fuse with autophagosomes and multivesicular bodies, and also lysosomes coordinate intracellular waste disposal via exocytosis [<xref rid="R6" ref-type="bibr">6</xref>]. Furthermore, mitochondria and lysosomes function as metabolic signaling hubs [<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R6" ref-type="bibr">6</xref>], which support metabolic and functional adaptation in T cells. Mitochondria are also at the interface of multiple cell death pathways and coordinate with lysosomes to regulate certain cell death mechanisms, such as ferroptosis, thereby contributing to the modulation of T cell-mediated immunity [<xref rid="R7" ref-type="bibr">7</xref>]. Therefore, mitochondria and lysosomes orchestrate T cell metabolism via effects on metabolic rewiring, organelle crosstalk, and signaling (<xref rid="F1" ref-type="fig">Figure 1</xref>, Key figure).</p><p id="P4">In this Review, we discuss mitochondria- and lysosome-directed metabolism in regulating T cell fate and function, with a primary focus on conventional &#945;&#946; T cells in mouse models (unless otherwise stated). We also describe mechanisms of organelle signaling and communication in T cell functional adaptation. Finally, the impact of dysregulated mitochondrial and lysosomal function on disease development is discussed, with a particular focus on autoimmunity, infectious disease, and cancer.</p></sec><sec id="S2"><title>Mitochondrial metabolism and fitness in T cell function</title><p id="P5">Mitochondrial metabolism is dynamically rewired during thymocyte development or upon mature T cell activation, and it promotes biosynthesis and energy production essential for <bold>quiescence exit</bold> and proliferation [<xref rid="R2" ref-type="bibr">2</xref>]. Consequently, mitochondrial metabolism shapes the fate decisions and function of developing and mature T cells as discussed in the following section.</p><sec id="S3"><title>Mitochondria in T cell development, activation, and differentiation</title><p id="P6">Thymocytes exhibit developmental stage-specific alterations in mitochondrial and glycolytic metabolism (<xref rid="F2" ref-type="fig">Figure 2A</xref>), and the balance between mitochondrial <bold>oxidative phosphorylation (OXPHOS)</bold> and <bold>glycolysis</bold> supports the lineage commitment of T cells. For example, glycolytic programming at the double-negative 3 (DN3) stage orchestrates &#945;&#946; over &#947;&#948; T cell development (mediated by mTORC1&#8211;MYC signaling) [<xref rid="R8" ref-type="bibr">8</xref>], with glycolysis and OXPHOS also contributing to IFN-&#947;<sup>+</sup> and IL-17<sup>+</sup> &#947;&#948; T cell generation, respectively [<xref rid="R9" ref-type="bibr">9</xref>]. Mitochondrial oxidation of pyruvate (mediated by mitochondrial pyruvate carrier; MPC1) shapes &#945;&#946; T cell maturation at multiple stages [&#946;-selection, immature single-positive (ISP)-to-double-positive (DP) transition, and positive selection] of development [<xref rid="R10" ref-type="bibr">10</xref>]. Mechanistically, Opa1 (mediates inner mitochondrial membrane fusion and cristae integrity) supports the metabolic quiescence of DN3 thymocytes [<xref rid="R11" ref-type="bibr">11</xref>], while DP and single-positive (SP) thymocytes increase Drp1-mediated <bold>mitochondrial fission</bold> to facilitate thymic egress and peripheral expansion [<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R13" ref-type="bibr">13</xref>]. Altogether, mitochondrial metabolism plays important roles in thymocyte development.</p><p id="P7">In mature T cells in the periphery, immune signals (e.g., cognate antigen&#8211;T cell receptor (TCR), co-stimulation) and nutrients (e.g., amino acids) support mitochondrial biogenesis and function [<xref rid="R2" ref-type="bibr">2</xref>], including <bold>one-carbon metabolism</bold> [<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref>] and ATP generation via the <bold>electron transport chain (ETC)</bold> [<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref>]. Inhibition of the one-carbon metabolism enzyme MTHFD2 impairs CD4<sup>+</sup> T cell activation and effector differentiation [<xref rid="R17" ref-type="bibr">17</xref>]. The ETC is also required for na&#239;ve CD4<sup>+</sup> T cell quiescence exit and proliferation (<xref rid="F2" ref-type="fig">Figure 2B</xref>) [<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R18" ref-type="bibr">18</xref>&#8211;<xref rid="R20" ref-type="bibr">20</xref>]. ETC complex I supports the activation and proliferation of CD4<sup>+</sup> T cells, while complex II facilitates <sc>T</sc><sub>H</sub>1 and <sc>T</sc><sub>H</sub>17 effector function [<xref rid="R21" ref-type="bibr">21</xref>]. Besides decreasing <bold>mitochondrial fusion,</bold> Opa1 ablation reduces mitochondrial respiration and enhances glutamine oxidation to impair T<sub>H</sub>17 effector function and ROR&#947;t expression via generation of metabolites that promote transcriptional remodeling [<xref rid="R22" ref-type="bibr">22</xref>], indicating that mitochondrial dynamics-related proteins can influence cellular functions at multiple levels. Therefore, mitochondria orchestrate CD4<sup>+</sup> T cell responses.</p><p id="P8">Mitochondria also control CD8<sup>+</sup> T cell fate and function (<xref rid="F2" ref-type="fig">Figure 2C</xref>). <bold>Mitochondrial membrane potential (MMP)</bold> maintains ETC efficiency and ATP production downstream of the <bold>tricarboxylic acid (TCA) cycle.</bold> Specifically, CD8<sup>+</sup> T cells with higher MMP have increased effector function [<xref rid="R23" ref-type="bibr">23</xref>] and migratory capacity [<xref rid="R24" ref-type="bibr">24</xref>] that correspond with increased mTORC1-driven glycolysis and reactive oxygen species (ROS) production [<xref rid="R23" ref-type="bibr">23</xref>], whereas those with lower MMP have enhanced self-renewal and survival, decreased mTORC1 activity and ROS production, and increased OXPHOS capacity [<xref rid="R23" ref-type="bibr">23</xref>]. Enhancing MMP via ablation of MCJ (a negative regulator of ETC complex I) bolsters the cytotoxic activity of effector CD8<sup>+</sup> T cells [<xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>]. Mitochondrial metabolism promotes CD8<sup>+</sup> T cell effector expansion via mitochondrial ROS-dependent NFAT activation [<xref rid="R27" ref-type="bibr">27</xref>], and mitochondrial translation maintains the cytolytic function of effector CD8<sup>+</sup> T cells by enabling synthesis of cytosolic proteins such as granzyme B and perforin [<xref rid="R28" ref-type="bibr">28</xref>]. Therefore, mitochondria shape CD8<sup>+</sup> T cell effector function.</p><p id="P9">Compared to effector cells, memory CD8<sup>+</sup> T cells have increased mitochondrial content and <bold>spare respiratory capacity (SRC)</bold> that are critical for rapid proliferation and survival upon antigen recall [<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>]. Accordingly, memory CD8<sup>+</sup> T cells have a fused mitochondrial network with densely packed cristae that support enhanced OXPHOS, while effector cells have more punctate mitochondria with looser cristae that enable them to better engage glycolysis [<xref rid="R31" ref-type="bibr">31</xref>]. Mitochondrial cardiolipin synthesis maintains mitochondrial fitness in circulating memory CD8<sup>+</sup> T cells [<xref rid="R32" ref-type="bibr">32</xref>] and poises CD8<sup>+</sup> tissue-resident memory (T<sub>RM</sub>) cells for activation [<xref rid="R33" ref-type="bibr">33</xref>]. CRISPR-based functional perturbation screens revealed that mitochondrial translation and ubiquinone synthesis underlie CD8<sup>+</sup>
<sc>T</sc><sub>RM</sub> formation and functional responses against tumors [<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R35" ref-type="bibr">35</xref>], establishing the central importance of mitochondria for CD8<sup>+</sup> T cell memory responses.</p><p id="P10">Finally, the effector function and lineage stability of CD4<sup>+</sup> Foxp3<sup>+</sup> Tregs are dependent on mitochondrial respiration (<xref rid="F2" ref-type="fig">Figure 2D</xref>). Impaired ETC activity in Tregs inhibits the generation of suppressive effector Tregs (eTregs) that maintain immune tolerance in lymphoid and nonlymphoid tissues [<xref rid="R36" ref-type="bibr">36</xref>&#8211;<xref rid="R38" ref-type="bibr">38</xref>]. mTORC1 [<xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R39" ref-type="bibr">39</xref>], MYC [<xref rid="R40" ref-type="bibr">40</xref>], and LKB1 [<xref rid="R41" ref-type="bibr">41</xref>,<xref rid="R42" ref-type="bibr">42</xref>] signaling enforces mitochondrial function in Tregs. Therefore, mitochondrial metabolism sustains Treg suppressive function to enforce immune homeostasis.</p></sec><sec id="S4"><title>Mitochondrial fitness combats T cell dysfunction</title><p id="P11">During chronic infection or cancer, chronic antigen stimulation promotes T cell exhaustion and a metabolic shift from OXPHOS to glycolysis [<xref rid="R43" ref-type="bibr">43</xref>]. CD8<sup>+</sup> T cell differentiation occurs from stem-like precursors of exhausted T (T<sub>pex</sub>) cells to terminally exhausted (T<sub>ex</sub>) cells via a transitory effector-like T<sub>ex</sub> state [<xref rid="R44" ref-type="bibr">44</xref>]. The accumulation of dysfunctional mitochondria facilitates <bold>terminal exhaustion</bold> by impairing stem-like T cell expansion [<xref rid="R45" ref-type="bibr">45</xref>] or inciting epigenetic reprogramming [<xref rid="R46" ref-type="bibr">46</xref>], and is accompanied by HIF-1&#945;-mediated metabolic reprogramming towards glycolysis due to the accumulation of ROS [<xref rid="R47" ref-type="bibr">47</xref>]. Further, acetyl-CoA generated from mitochondria-derived citrate contributes to terminal exhaustion programming through ACLY-KAT2A-mediated acetylation, while acetate-derived acetyl-CoA promotes <bold>stemness</bold> via the ACSS2-p300 acetyltransferase complex [<xref rid="R48" ref-type="bibr">48</xref>]. Beyond chronic stimulation, inhibitory molecules expressed by T cells can also alter mitochondrial dynamics or metabolism. For example, PD-1 signaling in CD8<sup>+</sup> T cells decreases Drp1-driven mitochondrial fission, thereby impairing T cell proliferation [<xref rid="R46" ref-type="bibr">46</xref>,<xref rid="R49" ref-type="bibr">49</xref>], while CTLA-4 signaling increases OXPHOS in CD4<sup>+</sup> T cells, thereby inhibiting their clonal expansion and egress from the lymph node to tumor [<xref rid="R50" ref-type="bibr">50</xref>]. Therefore, mitochondrial fitness helps combat T cell dysfunction in response to chronic antigen or inhibitory receptor stimulation.</p></sec></sec><sec id="S5"><title>Lysosome-directed metabolism and fitness in T cell function</title><p id="P12">Transportation of cytosolic components to the lysosome via non-selective <bold>macroautophagy</bold> (autophagy hereafter) and substrate-specific <bold>selective autophagy</bold> constitutes a major catabolic process in T cells responding to nutrient deprivation or cellular stress. This section discusses autophagy-dependent and -independent roles of lysosomes in T cell homeostasis and function (<xref rid="F3" ref-type="fig">Figure 3</xref>).</p><sec id="S6"><title>Lysosomes in T cell activation and differentiation</title><p id="P13">Autophagy is dynamically regulated in T cell states, with na&#239;ve and memory CD8<sup>+</sup> T cells exhibiting increased autophagy flux relative to effector CD8<sup>+</sup> T cells. Na&#239;ve CD8<sup>+</sup> T cells require autophagy to maintain expression of the lymphoid tissue homing receptor CD62L and increase mitophagy, which augments their survival by increasing expression of the anti-apoptotic protein MCL-1 (<xref rid="F3" ref-type="fig">Figure 3A</xref>) [<xref rid="R51" ref-type="bibr">51</xref>]. Likewise, memory CD8<sup>+</sup> T cells have reduced amino acid import and enhance autophagy flux to support their biosynthetic needs (<xref rid="F3" ref-type="fig">Figure 3B</xref>) [<xref rid="R51" ref-type="bibr">51</xref>]. Accordingly, autophagy inhibition compromises recall responses in CD8<sup>+</sup> and CD4<sup>+</sup> T cells (<xref rid="F3" ref-type="fig">Figure 3B</xref>) [<xref rid="R52" ref-type="bibr">52</xref>], and temporal analysis showed that autophagy flux is low during the activation and early effector stages, but increases immediately before the contraction phase [<xref rid="R53" ref-type="bibr">53</xref>]. Autophagy also regulates intratumoral CD8<sup>+</sup> T cell metabolism and function. High levels of extracellular potassium in the TME perturb nutrient uptake by CD8<sup>+</sup> T cells and induce a starvation-like state, resulting in elevated autophagy flux that is associated with increased T cell stemness but reduced effector function [<xref rid="R54" ref-type="bibr">54</xref>]. Conversely, autophagy inhibition via loss of Atg5 enhances glucose metabolism in CD8<sup>+</sup> T cells while reducing S-adenosylmethionine levels, thereby decreasing histone H3K27 trimethylation to support transcriptional programming for intratumoral effector memory CD8<sup>+</sup> T cell generation [<xref rid="R55" ref-type="bibr">55</xref>]. Therefore, autophagy has subset-dependent effects on T cell metabolism and function.</p><p id="P14">Beyond modulating memory and intratumoral CD8<sup>+</sup> T cell responses, autophagy is essential to maintain mitochondrial respiration and prevent anergy during CD4<sup>+</sup> T cell activation [<xref rid="R56" ref-type="bibr">56</xref>]. Tregs have increased autophagosome formation compared to conventional CD4<sup>+</sup> T cells [<xref rid="R57" ref-type="bibr">57</xref>], which supports their functional and metabolic fitness and survival (<xref rid="F3" ref-type="fig">Figure 3C</xref>) [<xref rid="R57" ref-type="bibr">57</xref>&#8211;<xref rid="R59" ref-type="bibr">59</xref>]. TRAFIP3-mediated inhibition of mTORC1, a negative regulator of autophagy, enhances Treg suppressive function [<xref rid="R60" ref-type="bibr">60</xref>], although autophagy inhibition reciprocally increases mTORC1 in Tregs (<xref rid="F3" ref-type="fig">Figure 3C</xref>) [<xref rid="R57" ref-type="bibr">57</xref>]. However, inhibiting autophagy may be an effective intervention for overcoming the immunosuppressive effects of intratumoral Tregs on antitumor immunity by decreasing their abundance in the tumor microenvironment (TME) [<xref rid="R57" ref-type="bibr">57</xref>&#8211;<xref rid="R59" ref-type="bibr">59</xref>]. Therefore, autophagy has cell type- and tissue-specific effects on T cell responses.</p><p id="P15">T cells also engage selective autophagy, which promotes T cell activation by degrading Itch and RCAN1, two negative regulators of TCR signaling [<xref rid="R61" ref-type="bibr">61</xref>], and supports activated T cell survival and proliferation by interplaying with mTORC1 signaling via TAX1BP1-dependent generation of <sc>l</sc>-cysteine (<xref rid="F3" ref-type="fig">Figure 3D</xref>) [<xref rid="R62" ref-type="bibr">62</xref>]. Selective autophagy also alters the differentiation trajectory of CD4<sup>+</sup> T cell subsets [<xref rid="R63" ref-type="bibr">63</xref>] and increases effector memory CD8<sup>+</sup> T cell differentiation via mitophagy (<xref rid="F3" ref-type="fig">Figure 3B</xref>) [<xref rid="R64" ref-type="bibr">64</xref>], indicating that the clearance of specific cargos plays an important role in T cell fate and function. Beyond marking damaged mitochondria for clearance, the mitophagy adaptors Parkin and Nix are essential to suppress VDAC1-dependent apoptosis and ROS-mediated ferroptosis in memory CD8<sup>+</sup> T cells, respectively (<xref rid="F3" ref-type="fig">Figure 3B</xref>) [<xref rid="R65" ref-type="bibr">65</xref>], highlighting multiple roles for selective autophagy in T cell biology.</p><p id="P16">Besides circulatory T cell populations, lysosomal processes also support functional T cell adaptation to tissue microenvironments. Human liver-resident T cells have increased autophagy flux corresponding to enhanced expression of tissue-homing or retention markers [<xref rid="R66" ref-type="bibr">66</xref>]. Ablation of Flcn or Rag GTPases, amino acid-dependent negative regulators of TFEB-coordinated lysosome biogenesis [<xref rid="R6" ref-type="bibr">6</xref>], facilitates enhanced T cell migration to and CD8<sup>+</sup> T<sub>RM</sub> differentiation in the small intestine to protect from intestinal infection (<xref rid="F3" ref-type="fig">Figure 3B</xref>) [<xref rid="R35" ref-type="bibr">35</xref>]. As intestinal CD8<sup>+</sup> T<sub>RM</sub> cells are enriched for lysosomes [<xref rid="R33" ref-type="bibr">33</xref>], these results indicate that lysosome-mediated nutrient sensing fosters tissue adaptation. Future investigation is warranted to fully understand the tissue-specific and temporal signals that lysosomes coordinate for CD8<sup>+</sup> T<sub>RM</sub> migration and differentiation.</p><p id="P17">Beyond autophagy, lysosomes orchestrate lipolysis in T cells via the lipid hydrolase lysosomal acid lipase (LAL) (<xref rid="F3" ref-type="fig">Figure 3B</xref>), which generates free fatty acids and cholesterol that can fuel mitochondrial respiration [<xref rid="R67" ref-type="bibr">67</xref>]. Enhancing LAL-mediated lipolysis enables memory CD8<sup>+</sup> T cell survival and recall responses [<xref rid="R30" ref-type="bibr">30</xref>]. Conversely, LAL-deficient T cells undergo metabolic reprogramming from fatty acid catabolism to glycolysis, which corresponds to increased T cell anergy in a mouse model of graft-versus-host disease [<xref rid="R68" ref-type="bibr">68</xref>]. Therefore, both autophagy-dependent and -independent lysosome-directed metabolism influence T cell fate and function.</p></sec></sec><sec id="S7"><title>Organelles as signaling platforms in T cell biology</title><p id="P18">Mitochondria and lysosomes mediate <bold>bidirectional metabolic signaling</bold> in T cells [<xref rid="R2" ref-type="bibr">2</xref>]. This section summarizes how mitochondria and lysosomes serve as platforms to integrate and regulate metabolic signaling processes in T cells (<xref rid="F4" ref-type="fig">Figure 4A</xref>,<xref rid="F4" ref-type="fig">B</xref>).</p><sec id="S8"><title>Mitochondria and lysosomes integrate extracellular cues for functional adaptation</title><p id="P19">Extracellular immune signals derived from co-stimulatory or cytokine receptors reprogram metabolism for T cell functional adaptation [<xref rid="R1" ref-type="bibr">1</xref>] (<xref rid="F1" ref-type="fig">Figure 1</xref>). For example, CD28 co-stimulation enhances memory CD8<sup>+</sup> T cell programming by transiently inhibiting miR-33 to promote mitochondrial cristae remodeling and increase SRC [<xref rid="R69" ref-type="bibr">69</xref>]. In CD8<sup>+</sup> T cells, 4&#8211;1BB co-stimulatory receptor engagement enhances PGC1&#945;-dependent mitochondrial fusion and biogenesis, and synergizes with anti-PD-1 therapy to improve antitumor immune responses [<xref rid="R70" ref-type="bibr">70</xref>]. Conversely, the cytokine Meteorin-like promotes intratumoral CD8<sup>+</sup> T cell hypofunction by inducing mitochondrial dysfunction [<xref rid="R71" ref-type="bibr">71</xref>]. In CD4<sup>+</sup> T cells, cytokine stimulation with IL-6 increases MMP and triggers calcium flux into mitochondria, thereby increasing in vivo migratory capacity [<xref rid="R72" ref-type="bibr">72</xref>]. Moreover, TNF-&#945; derived from na&#239;ve human CD4<sup>+</sup> T cells upon activation stimulates Akt&#8211;mTOR signaling to promote maximal mitochondrial mass and metabolic rewiring for T<sub>H</sub>1 and T<sub>H</sub>17 differentiation [<xref rid="R73" ref-type="bibr">73</xref>]. Therefore, multiple immune signals converge on mitochondria to affect T cell biology.</p><p id="P20">Beyond immune signals 1&#8211;3, nutrients serve as signal 4 for T cell activation and differentiation (<xref rid="F1" ref-type="fig">Figures 1</xref> and <xref rid="F4" ref-type="fig">4A</xref>) [<xref rid="R74" ref-type="bibr">74</xref>]. In particular, nutrient transport and sensing, together with nutrient-induced signal transduction at lysosomes, are important to license mTORC1 activity and metabolic rewiring in T cells (<xref rid="F4" ref-type="fig">Figure 4A</xref>) [<xref rid="R74" ref-type="bibr">74</xref>,<xref rid="R75" ref-type="bibr">75</xref>]. Besides impeding mTORC1 activation [<xref rid="R74" ref-type="bibr">74</xref>], glucose restriction also activates the AMPK&#8211;SENP1&#8211;Sirt3 axis to promote OXPHOS, mitochondrial fusion, and memory T cell formation [<xref rid="R76" ref-type="bibr">76</xref>]. Nutrients also impact CD8<sup>+</sup> T<sub>RM</sub> generation [<xref rid="R74" ref-type="bibr">74</xref>]. For example, dietary cholesterol and amino acids influence CD8<sup>+</sup> T<sub>RM</sub> formation through modulating SREBP2 and TFEB activity, respectively [<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R35" ref-type="bibr">35</xref>]. In nonimmune cells, the presence of cholesterol at the lysosomal membrane both recruits and activates mTORC1 through distinct pathways mediated by the GPCR-like protein LYCHOS [<xref rid="R77" ref-type="bibr">77</xref>] or the transmembrane SLC38A9-NPC1 complex [<xref rid="R78" ref-type="bibr">78</xref>], indicating that the lysosome serves as a sensor of nutrients beyond amino acids. Investigating these molecules and identifying other lysosome-mediated nutrient sensing and signaling functions in T cells will enhance our understanding of nutrient-dependent regulation of T cell fate and function [<xref rid="R74" ref-type="bibr">74</xref>].</p><p id="P21">Microenvironment-specific nutrients and metabolic signals can also alter T cell function. Intestinal CD8<sup>+</sup> T cells have increased mitochondrial depolarization due to gut-derived prostaglandin E<sub>2</sub> (PGE<sub>2</sub>); consequently, these cells increase autophagy and glutathione-dependent redox for functional adaptation to PGE<sub>2</sub> [<xref rid="R79" ref-type="bibr">79</xref>]. In the TME, long-term exposure to acidic pH reduces one-carbon metabolism and promotes stemness-related programming in intratumoral CD8<sup>+</sup> T cells [<xref rid="R80" ref-type="bibr">80</xref>], whereas hypoxia exacerbates chronic antigen-driven mitochondrial stress and CD8<sup>+</sup> T cell exhaustion [<xref rid="R81" ref-type="bibr">81</xref>]. Moreover, while PTPMT1-dependent mitochondrial oxidation of glucose-derived pyruvate supports intratumoral effector CD8<sup>+</sup> T cell function [<xref rid="R82" ref-type="bibr">82</xref>], CD8<sup>+</sup> T cells can adapt to use alternative nutrients when glucose is limited, such as inosine [<xref rid="R83" ref-type="bibr">83</xref>] or lipids [<xref rid="R84" ref-type="bibr">84</xref>]. Lactate has pH-dependent effects on CD8<sup>+</sup> T cells: pH-neutral sodium lactate increases antitumor immunity and augments T cell stemness by inhibiting histone deacetylation at the <italic toggle="yes">Tcf7</italic> locus [<xref rid="R85" ref-type="bibr">85</xref>], while lactate from the acidified TME inhibits effector function and contributes to metabolic dysfunction mediated by the transporter MCT11, which is selectively upregulated in exhausted CD8<sup>+</sup> T cells in response to chronic antigen stimulation [<xref rid="R86" ref-type="bibr">86</xref>]. Mechanistically, tumor-derived lactate rewires pyruvate metabolism by inhibiting pyruvate carboxylase-mediated generation of TCA cycle intermediates, thereby reducing autocrine signaling through the succinate receptor and compromising CD8<sup>+</sup> T cell cytotoxicity [<xref rid="R87" ref-type="bibr">87</xref>]. Lactate availability in the TME also influences Treg responses. Lactate import by MCT1 supports intratumoral Treg proliferation and suppressive function by fueling the TCA cycle and gluconeogenic metabolism, allowing Tregs to thrive in glucose-depleted environments like the TME [<xref rid="R88" ref-type="bibr">88</xref>]. In human Tregs, lactate regulates mitochondrial metabolism by XBP1-mediated transcription of MGAT1, which is subsequently translocated into mitochondria to increase N-glycosylation events that promote OXPHOS [<xref rid="R89" ref-type="bibr">89</xref>]. Together, mitochondria integrate extracellular cues to regulate T cell metabolic and functional adaptation.</p></sec><sec id="S9"><title>Mitochondria and lysosomes shape intracellular signaling</title><p id="P22">Mitochondria and lysosomes regulate mTORC1- and AMPK-mediated kinase signaling, thereby contributing to T cell metabolic adaptation. TCR-mediated mTORC1 activation is induced and sustained by amino acids and GTPases RagA/B and Rheb at the lysosome (<xref rid="F4" ref-type="fig">Figure 4A</xref>) [<xref rid="R90" ref-type="bibr">90</xref>,<xref rid="R91" ref-type="bibr">91</xref>], whereas mTORC1 recruitment to and activation at the lysosome are negatively regulated by the lysosomal protein NKG7 [<xref rid="R92" ref-type="bibr">92</xref>]. mTORC1 signaling coordinates multiple metabolic processes that orchestrate T cell quiescence exit, including glycolysis, lipid synthesis, and OXPHOS [<xref rid="R2" ref-type="bibr">2</xref>]. For example, Tregs have elevated mTORC1 activity compared to na&#239;ve T cells, which enhances mitochondrial metabolism and facilitates the expression of ICOS and CTLA-4 to establish suppressive function [<xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R39" ref-type="bibr">39</xref>]. Nutrient deprivation inhibits mTORC1 signaling and induces activation of the energy sensor AMPK (<xref rid="F4" ref-type="fig">Figure 4A</xref>), which promotes mitochondrial fitness essential for long-term T cell proliferation [<xref rid="R93" ref-type="bibr">93</xref>] and accumulation or persistence of central [<xref rid="R76" ref-type="bibr">76</xref>] and effector [<xref rid="R93" ref-type="bibr">93</xref>] memory T cell subsets. AMPK also supports glutamine-dependent mitochondrial metabolism and T cell survival during glucose restriction [<xref rid="R94" ref-type="bibr">94</xref>]. Therefore, mTORC1 and AMPK integrate nutrient cues to impact T cell functional adaptation.</p><p id="P23">Besides coordinating nutrient-dependent kinase signaling, a key function of mitochondrial metabolism is to generate metabolites that orchestrate transcriptional and epigenetic events (<xref rid="F4" ref-type="fig">Figure 4B</xref>). For example, the transcription factors TFAM [<xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R37" ref-type="bibr">37</xref>,<xref rid="R95" ref-type="bibr">95</xref>,<xref rid="R96" ref-type="bibr">96</xref>] and Eomes [<xref rid="R97" ref-type="bibr">97</xref>] regulate context-dependent functions of T cells and Tregs, partly by inducing transcriptional and epigenetic rewiring to enhance mitochondrial activity and support effector function. Specifically, TFAM prevents the development of proinflammatory CD4<sup>+</sup> T cell subsets by regulating the intracellular NAD<sup>+</sup>/NADH ratio to maintain lysosomal homeostasis (<xref rid="F4" ref-type="fig">Figure 4A</xref>) [<xref rid="R95" ref-type="bibr">95</xref>]. TFAM also prevents premature senescence induced by type 1 cytokines [<xref rid="R96" ref-type="bibr">96</xref>] and contributes to the maintenance of immune tolerance by Tregs [<xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R37" ref-type="bibr">37</xref>]. Conversely, Eomes is associated with pathogenic CD4<sup>+</sup> T cell responses that heighten inflammation in the central nervous system [<xref rid="R97" ref-type="bibr">97</xref>]. Moreover, acetyl-CoA derived from citrate by ACLY, or from acetate by ACSS2 in the context of ACLY deficiency, promotes mitochondrial respiration and chromatin accessibility of the <italic toggle="yes">Ifng</italic> and <italic toggle="yes">Gzmb</italic> loci, thereby enhancing effector CD8<sup>+</sup> T cell function in response to acute viral infection; these findings reveal that both citrate- and acetate-derived acetyl-CoA pools serve largely redundant roles in regulating effector CD8<sup>+</sup> T cell responses [<xref rid="R98" ref-type="bibr">98</xref>]. In contrast, ACLY provokes terminal exhaustion while ACSS2 supports stemness in CD8<sup>+</sup> T<sub>ex</sub> cells as described in the preceding text [<xref rid="R48" ref-type="bibr">48</xref>], suggesting context-dependent contributions of ACLY and ACSS2 to CD8<sup>+</sup> T cell programming. Acetyl-CoA also facilitates enrichment of acetylated H3K9 at the <italic toggle="yes">Ifng</italic> promoter to support intratumoral effector CD8<sup>+</sup> T cell function, which is reduced upon ACLY inhibitor treatment [<xref rid="R54" ref-type="bibr">54</xref>]. In CD8<sup>+</sup> T cells, the transcription factor Bhlhe40 facilitates the production of TCA metabolites and histone acetylation of effector gene loci necessary for CD8<sup>+</sup> T<sub>RM</sub> cell formation and function, which may be mediated in part by ACLY [<xref rid="R99" ref-type="bibr">99</xref>]. Acetyl-CoA production by ACLY is also associated with maintenance of CD4<sup>+</sup> T cell effector functions, including IFN-&#947; production by T<sub>H</sub>1 cells [<xref rid="R21" ref-type="bibr">21</xref>] and IL-17 production downstream of GLUT3-dependent glucose metabolism in T<sub>H</sub>17 cells [<xref rid="R100" ref-type="bibr">100</xref>]. Mitochondrial one-carbon metabolism is upregulated and promotes cell survival during na&#239;ve CD4<sup>+</sup> T cell activation [<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref>], and also generates S-adenosylmethionine that is the substrate for histone methylation reactions associated with epigenetic regulation (<xref rid="F4" ref-type="fig">Figure 4B</xref>) [<xref rid="R2" ref-type="bibr">2</xref>]. Besides mitochondrial metabolism, polyamine metabolism, regulated by the enzymes ODC1 and SAT1, governs CD4<sup>+</sup> T cell subset fidelity via transcriptional and epigenetic effects [<xref rid="R101" ref-type="bibr">101</xref>,<xref rid="R102" ref-type="bibr">102</xref>] or elF5A hypusination [<xref rid="R102" ref-type="bibr">102</xref>]. Therefore, multiple metabolic mechanisms regulate transcriptional and epigenetic rewiring in T cells. Identifying mechanisms for increasing mitochondria&#8211;nuclear crosstalk, such as via mitochondrial metabolites, may be permissive to tune T cell functional programming.</p><p id="P24">Nutrient signaling at lysosomes also contributes to transcriptional remodeling mediated by TFEB (<xref rid="F4" ref-type="fig">Figure 4A</xref>). Recent studies highlight that Treg-specific loss of TFEB (via CRISPR&#8211;Cas9 gene targeting) reduces Treg accumulation and causes mitochondrial dysfunction [<xref rid="R103" ref-type="bibr">103</xref>]. In contrast, hyperactivation of TFEB upon Flcn deletion induces CD8<sup>+</sup> T<sub>RM</sub> differentiation in the small intestine by promoting CCR9-mediated migration and TGF-&#946; signaling (<xref rid="F3" ref-type="fig">Figure 3B</xref>) [<xref rid="R35" ref-type="bibr">35</xref>], although TFEB hyperactivation in cDC1 cells inhibits glutamine-mediated licensing of intratumoral CD8<sup>+</sup> T cells [<xref rid="R104" ref-type="bibr">104</xref>]. Beyond transcription, lysosomal function can affect epigenetic modifications that alter T cell metabolism. For example, cancer cell-derived lactate induces histone lysine lactylation in intratumoral CD8<sup>+</sup> T cells, increasing lysosomal acidification and impeding MCT1-dependent lactate transport to the mitochondria for oxidative metabolism; such effects are rectified by lithium carbonate that induces TFEB-dependent LDHB expression necessary for lactate oxidation into pyruvate [<xref rid="R105" ref-type="bibr">105</xref>]. Moreover, delivery of nuclear SIRT1 to lysosomes by selective autophagy promotes senescence due to dysregulation of histone deacetylation [<xref rid="R106" ref-type="bibr">106</xref>], thereby supporting lysosome&#8211;epigenome crosstalk in T cell function. Therefore, mitochondria and lysosomes integrate nutrient-mediated intracellular signaling cues to establish metabolic control of transcriptional and epigenetic programming.</p></sec></sec><sec id="S10"><title>Organelle crosstalk in T cells</title><p id="P25">Organelle&#8211;organelle membrane contact sites regulate organelle communication. For example, endoplasmic reticulum (ER)-derived calcium influx into mitochondria via mitochondria&#8211;ER contact sites (MERCs) regulates T cell homeostasis and function (<xref rid="F4" ref-type="fig">Figure 4C</xref>). During thymocyte maturation, GRP75 promotes the survival and transition of DN3 thymocytes to the DN4 stage via MERCs by bridging interactions between IP3R (on ER) and VDAC1 (on outer mitochondrial membrane; OMM) [<xref rid="R107" ref-type="bibr">107</xref>]. ER-derived calcium flux into the mitochondria is partly regulated by phosphoenolpyruvate that blocks SERCA-mediated calcium uptake by the ER [<xref rid="R108" ref-type="bibr">108</xref>]. MERCs, mediated by MFN2 on the OMM and SERCA2 on the ER, support the proliferation and cytotoxicity of CD8<sup>+</sup> T cells in mouse syngeneic tumor models [<xref rid="R109" ref-type="bibr">109</xref>]. As such, transient enrichment of MERCs (e.g., by increasing membrane fluidity [<xref rid="R110" ref-type="bibr">110</xref>]) represents a useful strategy for elevating effector T cell function in the TME.</p><p id="P26">Regulation of interorganelle communication must remain intact, as both mitochondrial calcium overload and reduced calcium influx can negatively affect mitochondrial function and T cell metabolism. A genome-wide CRISPR screen in Jurkat T cells revealed that the ER transmembrane protein VMP1 regulates store-operated calcium entry by mediating calcium efflux from the ER, thereby preventing mitochondrial calcium overload and maintaining T cell survival [<xref rid="R111" ref-type="bibr">111</xref>]. Lysosomes are emerging as an additional regulator of mitochondrial calcium levels, and a recent study in NK cells revealed that lysosomes regulate mitochondrial calcium influx through the calcium channel TRPML1, indicating an essential role for mitochondria&#8211;lysosome crosstalk in cellular fitness [<xref rid="R112" ref-type="bibr">112</xref>]. Although mitochondria&#8211;lysosome interactions are not yet described in T cells, future studies should explore roles for mitochondria&#8211;lysosome contact sites and other types of organelle&#8211;organelle crosstalk in T cell fitness.</p><p id="P27">Organelle crosstalk is also facilitated by extracellular cues that promote the simultaneous activation of multiple intracellular pathways. For example, CD2 co-stimulation of CD8<sup>+</sup> T cells promotes AMPK localization to lysosomes, where AMPK mediates lytic granule polarization towards the immune synapse and enhances cytotoxicity [<xref rid="R113" ref-type="bibr">113</xref>]. Together, these studies suggest that multiple layers of regulation on organelle contact sites are required to maintain optimal T cell function. Beyond intracellular organelle crosstalk, emerging studies show that organelles facilitate communication between cells; the functional consequences of intercellular mitochondria transfer are discussed in <xref rid="BX4" ref-type="boxed-text">Box 1</xref>.</p></sec><sec id="S11"><title>Mitochondria and lysosomes in immune-mediated diseases</title><p id="P28">The functional interdependence of mitochondrial and lysosomal activity extends to disease development and progression [<xref rid="R114" ref-type="bibr">114</xref>]. For example, autophagy is rapidly induced during the early transition phase of effector to memory CD8<sup>+</sup> T cell differentiation during LCMV (both Armstrong and clone 13 strains) infection, and promotes mitochondria&#8211;lysosome crosstalk to maintain memory T cell metabolism [<xref rid="R53" ref-type="bibr">53</xref>]. Autophagy controls oxidative stress in hypoxic tissues, and Atg5-deficient CD8<sup>+</sup> T cells have increased expression of proapoptotic p53 that leads to cell death due to ROS accumulation [<xref rid="R115" ref-type="bibr">115</xref>]. Redox balance is an essential mediator of T cell function. Accordingly, reduced production of the antioxidant glutathione by genetic ablation of the catalytic subunit Gclc promotes the accumulation of ROS and mitochondrial dysfunction in intestinal T<sub>H</sub>17 cells, leading to impaired IL-22 production that is necessary for intestinal tissue integrity and clearance of <italic toggle="yes">Citrobacter rodentium</italic> infection [<xref rid="R116" ref-type="bibr">116</xref>]. Likewise, loss of Opa1 compromises the maintenance of tissue-resident T<sub>H</sub>17 cells that prevent intestinal inflammation arising from commensal pathogens [<xref rid="R22" ref-type="bibr">22</xref>]. The contribution of lysosomes or autophagy to glutathione-mediated redox balance or control of intestinal pathogens requires further investigation.</p><p id="P29">Environmental stressors have context-dependent effects on mitochondria- or lysosome-mediated T cell responses. For example, febrile temperatures induced by infection augment mitochondrial gene transcription and enhance CD8<sup>+</sup> T cell effector function [<xref rid="R117" ref-type="bibr">117</xref>]. Nutrient deprivation is another source of environmental stress and is commonly associated with the immunosuppressive TME, leading to metabolic dysfunction in intratumoral T cell populations and tumor immune evasion [<xref rid="R118" ref-type="bibr">118</xref>]. Consequently, aberrant metabolic reprogramming in the TME can contribute to CD8<sup>+</sup> T cell exhaustion as discussed in the preceding text [<xref rid="R43" ref-type="bibr">43</xref>,<xref rid="R45" ref-type="bibr">45</xref>,<xref rid="R46" ref-type="bibr">46</xref>,<xref rid="R48" ref-type="bibr">48</xref>,<xref rid="R54" ref-type="bibr">54</xref>,<xref rid="R81" ref-type="bibr">81</xref>]. The TME also compromises the metabolic adaptation of conventional CD4<sup>+</sup> T cells by promoting Treg-mediated inhibition of CD4<sup>+</sup> T cell glycolytic metabolism via CTLA-4 [<xref rid="R50" ref-type="bibr">50</xref>]. Since Tregs are a frequent barrier to antitumor immunity [<xref rid="R118" ref-type="bibr">118</xref>], using bimodal therapeutic strategies that improve conventional T cell function while simultaneously reducing Treg-mediated immunosuppression is promising. To this end, introducing mitochondrial DNA (mtDNA) mutations that support effector T cell metabolism while suppressing Treg function [<xref rid="R119" ref-type="bibr">119</xref>] or inhibiting autophagy to promote effector memory T cell differentiation [<xref rid="R55" ref-type="bibr">55</xref>] and reduce Treg accumulation in the TME [<xref rid="R57" ref-type="bibr">57</xref>&#8211;<xref rid="R59" ref-type="bibr">59</xref>] are intriguing options for enhancing antitumor immunity.</p><p id="P30">Mitochondrial and lysosomal alterations are also evident in autoimmunity. For example, in mice with experimental autoimmune encephalomyelitis, the transcription factor Eomes enhances mitochondrial mass and oxidative metabolism that promotes the persistence and survival of highly inflammatory CD4<sup>+</sup> Eomes<sup>+</sup> T cells [<xref rid="R97" ref-type="bibr">97</xref>]. Similarly, in rheumatoid arthritis (RA), enhanced TNF-&#945; secretion upon CD4<sup>+</sup> T cell activation coordinates mitochondrial expansion and increases IL-17 and IFN-&#947; production associated with RA pathology [<xref rid="R73" ref-type="bibr">73</xref>]. Proinflammatory cytokines derived from T cells may induce microenvironmental metabolic changes that establish autoimmunity, such as the muscle damage and weakness mediated by IFN-&#947;-producing T<sub>H</sub>1 cells in <italic toggle="yes">Icos</italic><sup><italic toggle="yes">&#8211;/&#8211;</italic></sup> nonobese diabetic mice [<xref rid="R120" ref-type="bibr">120</xref>]. During autoimmunity, Tregs exhibit mitochondrial oxidative stress that inhibits lysosomal function and restricts mitophagy, resulting in Treg dysfunction, activation of DNA damage response, and cell death [<xref rid="R121" ref-type="bibr">121</xref>]. Lymphocytes isolated from patients with autoimmune diseases have increased autophagy flux and mitochondrial activity, and inhibiting autophagy during CD4<sup>+</sup> T cell activation induces long-lasting hyporesponsiveness and decreases the severity of autoimmunity by promoting T cell anergy [<xref rid="R56" ref-type="bibr">56</xref>]. Therefore, inhibiting mitochondrial function or altering mitochondria&#8211;lysosome crosstalk may be effective methods for controlling autoimmune diseases.</p><p id="P31">Beyond immune-mediated diseases, organelle dysfunction in T cells is also emerging in human inborn errors of immunity (IEIs) and metabolic diseases. A metabolic CRISPR screen showed that inactivating the IEI gene <italic toggle="yes">Bcl11b</italic> impairs the thymic differentiation and mitochondrial metabolism of T cells, explaining why patients with <italic toggle="yes">BCL11B</italic> mutations develop combined immunodeficiency with low T cell numbers [<xref rid="R122" ref-type="bibr">122</xref>]. Future studies should continue to explore the interplay between these diseases, organelles, and immunometabolism.</p></sec><sec id="S12"><title>Concluding remarks</title><p id="P32">Mitochondria and lysosomes and their interplay with metabolism serve important roles in T cell fate and function, though many questions remain (see <xref rid="BX3" ref-type="boxed-text">Outstanding questions</xref>). In particular, context (i.e., tissue or cell state)-specific functions of these organelles remain to be fully elucidated. Unbiased tools like single-cell CRISPR screens [<xref rid="R123" ref-type="bibr">123</xref>&#8211;<xref rid="R126" ref-type="bibr">126</xref>] or single-cell-level metabolic flux analysis (e.g., COMPASS [<xref rid="R101" ref-type="bibr">101</xref>] or SCENITH [<xref rid="R127" ref-type="bibr">127</xref>]) will provide additional mechanistic insight for such context specificity. Applying methods to model organelle contact sites [<xref rid="R128" ref-type="bibr">128</xref>] and developing more advanced imaging tools to better define organelle-directed metabolic rewiring with intra-tissue or subcellular resolution will enhance our understanding of organelle biology in T cells. Finally, future studies are warranted to identify or repurpose therapeutic agents to modify the activity of these organelles while limiting off-target effects (<xref rid="T1" ref-type="table">Table 1</xref>). Collectively, these studies will advance our ability to target these organelles to modulate T cell function to treat diseases.</p></sec></body><back><ack id="S13"><title>Acknowledgments</title><p id="P33">The authors thank H. Shi, J. Raynor, J. Saravia, and X. Sun for insightful scientific discussions. We apologize to our colleagues whose work is not highlighted due to space constraints. This work was supported by American Lebanese Syrian Associated Charities (ALSAC), National Institutes of Health (NIH) grants CA253188, CA281868, Al131703, Al105887, Al140761, Al150241, and Al150514 (to H.C.) and F31Al186413 (to E.G.N.), and the Lupus Research Alliance. Figures were generated using BioRender. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.</p></ack><fn-group><fn fn-type="COI-statement" id="FN1"><p id="P34">Declaration of interests</p><p id="P35">H.C. consults for Kumquat Biosciences, Inc. and TCura Bioscience and is a co-inventor on patents/patent applications in the field of immunotherapy. E.G.N. and N.M.C have no competing interests to declare.</p></fn></fn-group><glossary><title>Glossary</title><def-list><def-item><term>Bidirectional metabolic signaling</term><def><p id="P36">intracellular crosstalk between signal transduction and metabolic reprogramming that orchestrates T cell fate and function.</p></def></def-item><def-item><term>Electron transport chain (ETC)</term><def><p id="P37">composed of five Individual subunits (complexes I&#8211;V) that facilitate electron transfer and proton pumping for ATP production; ETC complex II links the ETC to the TCA cycle.</p></def></def-item><def-item><term>Glycolysis</term><def><p id="P38">a metabolic pathway that breaks down glucose into intermediates to fuel biosynthetic processes and lactate production in activated T cells.</p></def></def-item><def-item><term>Immunometabolism</term><def><p id="P39">the concept that metabolism-associated processes (e.g., energy production, biosynthesis) and metabolic signaling direct the outcomes of immune responses.</p></def></def-item><def-item><term>Macroautophagy</term><def><p id="P40">a lysosome-associated catabolic process that non-specifically shuttles protein aggregates, damaged organelles, or other cytosolic components for degradation, especially under conditions of cellular or nutrient stress.</p></def></def-item><def-item><term>Mitochondrial fission</term><def><p id="P41">the process by which the outer mitochondrial membranes between two mitochondria physically separate (facilitated by Drp1), thereby forming two discrete mitochondria.</p></def></def-item><def-item><term>Mitochondrial fusion</term><def><p id="P42">the process by which mitochondria fuse with each other or other organelles. MFN1 and OPA1 facilitate mitochondrial elongation and cristae remodeling via regulating fusion of the outer and inner mitochondrial membranes, respectively; MFN2 regulates outer mitochondrial membrane fusion to the ER to facilitate interorganelle crosstalk.</p></def></def-item><def-item><term>Mitochondrial membrane potential (MMP)</term><def><p id="P43">the electrical gradient across the inner mitochondrial membrane generated by complexes I, III, and IV of the electron transport chain; serves as a key indicator of mitochondrial fitness.</p></def></def-item><def-item><term>One-carbon metabolism</term><def><p id="P44">metabolic pathways (e.g., folate and methionine cycles) that utilize one-carbon units to drive purine synthesis and methylation reactions.</p></def></def-item><def-item><term>Oxidative phosphorylation (OXPHOS)</term><def><p id="P45">a metabolic process that links nutrient catabolism to the generation of metabolic intermediates, protons, and ATP.</p></def></def-item><def-item><term>Quiescence exit</term><def><p id="P46">a highly regulated process, initiated by antigen and co-stimulatory signals, that is characterized by dynamic epigenomic, transcriptomic, proteomic, and metabolic rewiring necessary for na&#239;ve or memory T cells to undergo cell division.</p></def></def-item><def-item><term>Selective autophagy</term><def><p id="P47">type of autophagy that is facilitated by distinct cellular chaperones to orchestrate the regulated turnover of cellular components such as organelles, metabolites, or proteins.</p></def></def-item><def-item><term>Spare respiratory capacity (SRC)</term><def><p id="P48">in a Seahorse metabolic flux assay, the difference between maximal and basal cellular respiration based on oxygen consumption rate readings; SRC indicates the cellular capacity to increase oxidative metabolism in response to energy demand or stress.</p></def></def-item><def-item><term>Stemness</term><def><p id="P49">state of adaptation that corresponds with increased longevity, self-renewal, and differentiation capacity.</p></def></def-item><def-item><term>Terminal exhaustion</term><def><p id="P50">hypofunctional state of adaptation that occurs under conditions of chronic antigen stimulation, defined by discrete epigenomic, transcriptomic, proteomic, and metabolic signatures.</p></def></def-item><def-item><term>Tricarboxylic acid (TCA) cycle</term><def><p id="P51">a metabolic pathway that links nutrient catabolism with energy production (via mitochondria) and biosynthesis for cell growth and proliferation; intermediates from this metabolic pathway also contribute to epigenomic remodeling.</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chi</surname><given-names>H</given-names></name><etal/> (<year>2024</year>) <article-title>Principles and therapeutic applications of adaptive immunity</article-title>. <source>Cell</source><volume>187</volume>, <fpage>2052</fpage>&#8211;<lpage>2078</lpage><pub-id pub-id-type="pmid">38670065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2024.03.037</pub-id><pub-id pub-id-type="pmcid">PMC11177542</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chapman</surname><given-names>NM</given-names></name><etal/> (<year>2020</year>) <article-title>Metabolic coordination of T cell quiescence and activation</article-title>. <source>Nat. Rev. Immunol</source><volume>20</volume>, <fpage>55</fpage>&#8211;<lpage>70</lpage><pub-id pub-id-type="pmid">31406325</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41577-019-0203-y</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Steinert</surname><given-names>EM</given-names></name><etal/> (<year>2021</year>) <article-title>Mitochondrial metabolism regulation of T cell-mediated immunity</article-title>. <source>Annu. Rev. Immunol</source><volume>39</volume>, <fpage>395</fpage>&#8211;<lpage>416</lpage><pub-id pub-id-type="pmid">33902315</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-immunol-101819-082015</pub-id><pub-id pub-id-type="pmcid">PMC10403253</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Giacomello</surname><given-names>M</given-names></name><etal/> (<year>2020</year>) <article-title>The cell biology of mitochondrial membrane dynamics</article-title>. <source>Nat. Rev. Mol. Cell Biol</source><volume>21</volume>, <fpage>204</fpage>&#8211;<lpage>224</lpage><pub-id pub-id-type="pmid">32071438</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41580-020-0210-7</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ballabio</surname><given-names>A</given-names></name> and <name name-style="western"><surname>Bonifacino</surname><given-names>JS</given-names></name> (<year>2020</year>) <article-title>Lysosomes as dynamic regulators of cell and organismal homeostasis</article-title>. <source>Nat. Rev. Mol. Cell Biol</source><volume>21</volume>, <fpage>101</fpage>&#8211;<lpage>118</lpage><pub-id pub-id-type="pmid">31768005</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41580-019-0185-4</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jin</surname><given-names>J</given-names></name><etal/> (<year>2021</year>) <article-title>Lysosomes in T cell immunity and aging</article-title>. <source>Front. Aging</source><volume>2</volume>, <fpage>809539</fpage><pub-id pub-id-type="pmid">35822050</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fragi.2021.809539</pub-id><pub-id pub-id-type="pmcid">PMC9261317</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bell</surname><given-names>HN</given-names></name><etal/> (<year>2024</year>) <article-title>Ironing out the role of ferroptosis in immunity</article-title>. <source>Immunity</source><volume>57</volume>, <fpage>941</fpage>&#8211;<lpage>956</lpage><pub-id pub-id-type="pmid">38749397</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2024.03.019</pub-id><pub-id pub-id-type="pmcid">PMC11101142</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>yang</surname><given-names>K</given-names></name><etal/> (<year>2018</year>) <article-title>Metabolic signaling directs the reciprocal lineage decisions of &#945;&#946; and &#947;&#948; T cells</article-title>. <source>Sci. Immunol</source><volume>3</volume>, <fpage>eaas9818</fpage><pub-id pub-id-type="pmid">29980617</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.aas9818</pub-id><pub-id pub-id-type="pmcid">PMC6230375</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lopes</surname><given-names>N</given-names></name><etal/> (<year>2021</year>) <article-title>Distinct metabolic programs established in the thymus control effector functions of &#947;&#948; T cell subsets in tumor microenvironments</article-title>. <source>Nat. Immunol</source><volume>22</volume>, <fpage>179</fpage>&#8211;<lpage>192</lpage><pub-id pub-id-type="pmid">33462452</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-020-00848-3</pub-id><pub-id pub-id-type="pmcid">PMC7610600</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ramstead</surname><given-names>AG</given-names></name><etal/> (<year>2020</year>) <article-title>Mitochondrial pyruvate carrier 1 promotes peripheral T cell homeostasis through metabolic regulation of thymic development</article-title>. <source>Cell Rep</source><volume>30</volume>, <fpage>2889</fpage>&#8211;<lpage>2899</lpage>.e2886<pub-id pub-id-type="pmid">32130894</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2020.02.042</pub-id><pub-id pub-id-type="pmcid">PMC7170217</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Corrado</surname><given-names>M</given-names></name><etal/> (<year>2021</year>) <article-title>Deletion of the mitochondria-shaping protein Opa1 during early thymocyte maturation impacts mature memory T cell metabolism</article-title>. <source>Cell Death Differ</source><volume>28</volume>, <fpage>2194</fpage>&#8211;<lpage>2206</lpage><pub-id pub-id-type="pmid">33649469</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41418-021-00747-6</pub-id><pub-id pub-id-type="pmcid">PMC8257785</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Elhage</surname><given-names>R</given-names></name><etal/> (<year>2024</year>) <article-title>Mitochondrial dynamics and metabolic regulation control T cell fate in the thymus</article-title>. <source>Front. Immunol</source><volume>14</volume>, <fpage>1270268</fpage><pub-id pub-id-type="pmid">38288115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2023.1270268</pub-id><pub-id pub-id-type="pmcid">PMC10822881</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Simula</surname><given-names>L</given-names></name><etal/> (<year>2018</year>) <article-title>Drp1 controls effective T cell immune-surveillance by regulating T cell migration, proliferation, and cMyc-dependent metabolic reprogramming</article-title>. <source>Cell Rep</source><volume>25</volume>, <fpage>3059</fpage>&#8211;<lpage>3073</lpage>.e3010<pub-id pub-id-type="pmid">30540939</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2018.11.018</pub-id><pub-id pub-id-type="pmcid">PMC6302735</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ron-Harel</surname><given-names>N</given-names></name><etal/> (<year>2016</year>) <article-title>Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation</article-title>. <source>Cell Metab</source><volume>24</volume>, <fpage>104</fpage>&#8211;<lpage>117</lpage><pub-id pub-id-type="pmid">27411012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2016.06.007</pub-id><pub-id pub-id-type="pmcid">PMC5330619</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tan</surname><given-names>H</given-names></name><etal/> (<year>2017</year>) <article-title>Integrative proteomics and phosphoproteomics profiling reveals dynamic signaling networks and bioenergetics pathways underlying T cell activation</article-title>. <source>Immunity</source><volume>46</volume>, <fpage>488</fpage>&#8211;<lpage>503</lpage><pub-id pub-id-type="pmid">28285833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2017.02.010</pub-id><pub-id pub-id-type="pmcid">PMC5466820</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ron-Harel</surname><given-names>N</given-names></name><etal/> (<year>2019</year>) <article-title>T cell activation depends on extracellular alanine</article-title>. <source>Cell Rep</source><volume>28</volume>, <fpage>3011</fpage>&#8211;<lpage>3021</lpage>.e3014<pub-id pub-id-type="pmid">31533027</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2019.08.034</pub-id><pub-id pub-id-type="pmcid">PMC6934407</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sugiura</surname><given-names>A</given-names></name><etal/> (<year>2022</year>) <article-title>MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function</article-title>. <source>Immunity</source><volume>55</volume>, <fpage>65</fpage>&#8211;<lpage>81</lpage>.e69<pub-id pub-id-type="pmid">34767747</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2021.10.011</pub-id><pub-id pub-id-type="pmcid">PMC8755618</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tarasenko</surname><given-names>TN</given-names></name><etal/> (<year>2017</year>) <article-title>Cytochrome c oxidase activity is a metabolic checkpoint that regulates cell fate decisions during T cell activation and differentiation</article-title>. <source>Cell Metab</source><volume>25</volume>, <fpage>1254</fpage>&#8211;<lpage>1268</lpage>.e1257<pub-id pub-id-type="pmid">28591633</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2017.05.007</pub-id><pub-id pub-id-type="pmcid">PMC5562283</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Previte</surname><given-names>DM</given-names></name><etal/> (<year>2019</year>) <article-title>Lymphocyte activation gene-3 maintains mitochondrial and metabolic quiescence in naive CD4<sup>+</sup> T cells</article-title>. <source>Cell Rep</source><volume>27</volume>, <fpage>129</fpage>&#8211;<lpage>141</lpage>.e124<pub-id pub-id-type="pmid">30943396</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2019.03.004</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chang</surname><given-names>C-H</given-names></name><etal/> (<year>2013</year>) <article-title>Posttranscriptional control of T cell effector function by aerobic glycolysis</article-title>. <source>Cell</source><volume>153</volume>, <fpage>1239</fpage>&#8211;<lpage>1251</lpage><pub-id pub-id-type="pmid">23746840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2013.05.016</pub-id><pub-id pub-id-type="pmcid">PMC3804311</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bailis</surname><given-names>W</given-names></name><etal/> (<year>2019</year>) <article-title>Distinct modes of mitochondrial metabolism uncouple T cell differentiation and function</article-title>. <source>Nature</source><volume>571</volume>, <fpage>403</fpage>&#8211;<lpage>407</lpage><pub-id pub-id-type="pmid">31217581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-019-1311-3</pub-id><pub-id pub-id-type="pmcid">PMC6939459</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Baixauli</surname><given-names>F</given-names></name><etal/> (<year>2022</year>) <article-title>An LKB1&#8211;mitochondria axis controls T<sub>H</sub>17 effector function</article-title>. <source>Nature</source><volume>610</volume>, <fpage>555</fpage>&#8211;<lpage>561</lpage><pub-id pub-id-type="pmid">36171294</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-022-05264-1</pub-id><pub-id pub-id-type="pmcid">PMC9844518</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sukumar</surname><given-names>M</given-names></name><etal/> (<year>2016</year>) <article-title>Mitochondrial membrane potential identifies cells with enhanced stemness for cellular therapy</article-title>. <source>Cell Metab</source><volume>23</volume>, <fpage>63</fpage>&#8211;<lpage>76</lpage><pub-id pub-id-type="pmid">26674251</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2015.11.002</pub-id><pub-id pub-id-type="pmcid">PMC4747432</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Simula</surname><given-names>L</given-names></name><etal/> (<year>2024</year>) <article-title>Mitochondrial metabolism sustains CD8<sup>+</sup> T cell migration for an efficient infiltration into solid tumors</article-title>. <source>Nat. Commun</source><volume>15</volume>, <fpage>2203</fpage><pub-id pub-id-type="pmid">38467616</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-46377-7</pub-id><pub-id pub-id-type="pmcid">PMC10928223</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wu</surname><given-names>M-H</given-names></name><etal/> (<year>2024</year>) <article-title>Deleting the mitochondrial respiration negative regulator MCJ enhances the efficacy of CD8<sup>+</sup> T cell adoptive therapies in pre-clinical studies</article-title>. <source>Nat. Commun</source><volume>15</volume>, <fpage>4444</fpage><pub-id pub-id-type="pmid">38789421</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-48653-y</pub-id><pub-id pub-id-type="pmcid">PMC11126743</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Champagne</surname><given-names>DP</given-names></name><etal/> (<year>2016</year>) <article-title>Fine-tuning of CD8<sup>+</sup> T cell mitochondrial metabolism by the respiratory chain repressor MCJ dictates protection to influenza virus</article-title>. <source>Immunity</source><volume>44</volume>, <fpage>1299</fpage>&#8211;<lpage>1311</lpage><pub-id pub-id-type="pmid">27234056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2016.02.018</pub-id><pub-id pub-id-type="pmcid">PMC4917451</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sena</surname><given-names>A</given-names></name><etal/> (<year>2013</year>) <article-title>Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling</article-title>. <source>Immunity</source><volume>38</volume>, <fpage>225</fpage>&#8211;<lpage>236</lpage><pub-id pub-id-type="pmid">23415911</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2012.10.020</pub-id><pub-id pub-id-type="pmcid">PMC3582741</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lisci</surname><given-names>M</given-names></name><etal/> (<year>2021</year>) <article-title>Mitochondrial translation is required for sustained killing by cytotoxic T cells</article-title>. <source>Science</source><volume>374</volume>, <fpage>eabe9977</fpage><pub-id pub-id-type="pmid">34648346</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.abe9977</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>van der Windt</surname><given-names>JW</given-names></name><etal/> (<year>2012</year>) <article-title>Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development</article-title>. <source>Immunity</source><volume>36</volume>, <fpage>68</fpage>&#8211;<lpage>78</lpage><pub-id pub-id-type="pmid">22206904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2011.12.007</pub-id><pub-id pub-id-type="pmcid">PMC3269311</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>D</given-names></name><etal/> (<year>2014</year>) <article-title>Memory CD8<sup>+</sup> T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development</article-title>. <source>Immunity</source><volume>41</volume>, <fpage>75</fpage>&#8211;<lpage>88</lpage><pub-id pub-id-type="pmid">25001241</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2014.06.005</pub-id><pub-id pub-id-type="pmcid">PMC4120664</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Buck</surname><given-names>D</given-names></name><etal/> (<year>2016</year>) <article-title>Mitochondrial dynamics controls T cell fate through metabolic programming</article-title>. <source>Cell</source><volume>166</volume>, <fpage>63</fpage>&#8211;<lpage>76</lpage><pub-id pub-id-type="pmid">27293185</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2016.05.035</pub-id><pub-id pub-id-type="pmcid">PMC4974356</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Corrado</surname><given-names>M</given-names></name><etal/> (<year>2020</year>) <article-title>Dynamic cardiolipin synthesis is required for CD8<sup>+</sup> T cell immunity</article-title>. <source>Cell Metab</source><volume>32</volume>, <fpage>981</fpage>&#8211;<lpage>995</lpage>.e987<pub-id pub-id-type="pmid">33264603</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2020.11.003</pub-id><pub-id pub-id-type="pmcid">PMC7721104</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Konjar</surname><given-names>&#352;</given-names></name><etal/> (<year>2018</year>) <article-title>Mitochondria maintain controlled activation state of epithelial-resident T lymphocytes</article-title>. <source>Sci. Immunol</source><volume>3</volume>, <fpage>eaan2543</fpage><pub-id pub-id-type="pmid">29934344</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.aan2543</pub-id><pub-id pub-id-type="pmcid">PMC6690060</pub-id></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Reina-Campos</surname><given-names>M</given-names></name><etal/> (<year>2023</year>) <article-title>Metabolic programs of T cell tissue residency empower tumour immunity</article-title>. <source>Nature</source><volume>621</volume>, <fpage>179</fpage>&#8211;<lpage>187</lpage><pub-id pub-id-type="pmid">37648857</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-023-06483-w</pub-id><pub-id pub-id-type="pmcid">PMC11238873</pub-id></mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Raynor</surname><given-names>JL</given-names></name><etal/> (<year>2024</year>) <article-title>CRISPR screens unveil nutrient-dependent lysosomal and mitochondrial nodes impacting intestinal tissue-resident memory CD8<sup>+</sup> T cell formation</article-title>. <source>Immunity</source><volume>57</volume>, <fpage>2597</fpage>&#8211;<lpage>2614</lpage>.e2513<pub-id pub-id-type="pmid">39406246</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2024.09.013</pub-id><pub-id pub-id-type="pmcid">PMC11590283</pub-id></mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chapman</surname><given-names>NM</given-names></name><etal/> (<year>2018</year>) <article-title>mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis</article-title>. <source>Nat. Commun</source><volume>9</volume>, <fpage>2095</fpage><pub-id pub-id-type="pmid">29844370</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-018-04392-5</pub-id><pub-id pub-id-type="pmcid">PMC5974344</pub-id></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Fu</surname><given-names>Z</given-names></name><etal/> (<year>2019</year>) <article-title>Requirement of mitochondrial transcription factor A in tissue-resident regulatory T cell maintenance and function</article-title>. <source>Cell Rep</source><volume>28</volume>, <fpage>159</fpage>&#8211;<lpage>171</lpage>.e154<pub-id pub-id-type="pmid">31269437</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2019.06.024</pub-id><pub-id pub-id-type="pmcid">PMC6679941</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weinberg</surname><given-names>SE</given-names></name><etal/> (<year>2019</year>) <article-title>Mitochondrial complex III is essential for suppressive function of regulatory T cells</article-title>. <source>Nature</source><volume>565</volume>, <fpage>495</fpage>&#8211;<lpage>499</lpage><pub-id pub-id-type="pmid">30626970</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-018-0846-z</pub-id><pub-id pub-id-type="pmcid">PMC6345596</pub-id></mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zeng</surname><given-names>H</given-names></name><etal/> (<year>2013</year>) <article-title>mTORC1 couples immune signals and metabolic programming to establish T<sub>reg</sub>-cell function</article-title>. <source>Nature</source><volume>499</volume>, <fpage>485</fpage>&#8211;<lpage>490</lpage><pub-id pub-id-type="pmid">23812589</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature12297</pub-id><pub-id pub-id-type="pmcid">PMC3759242</pub-id></mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Saravia</surname><given-names>J</given-names></name><etal/> (<year>2020</year>) <article-title>Homeostasis and transitional activation of regulatory T cells require c-Myc</article-title>. <source>Sci. Adv</source><volume>6</volume>, <fpage>eaaw6443</fpage><pub-id pub-id-type="pmid">31911938</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciadv.aaw6443</pub-id><pub-id pub-id-type="pmcid">PMC6938709</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yang</surname><given-names>K</given-names></name><etal/> (<year>2017</year>) <article-title>Homeostatic control of metabolic and functional fitness of Treg cells by LKB1 signalling</article-title>. <source>Nature</source><volume>548</volume>, <fpage>602</fpage>&#8211;<lpage>606</lpage><pub-id pub-id-type="pmid">28847007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature23665</pub-id><pub-id pub-id-type="pmcid">PMC5804356</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>He</surname><given-names>N</given-names></name><etal/> (<year>2017</year>) <article-title>Metabolic control of regulatory T cell (Treg) survival and function by Lkb1</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source><volume>114</volume>, <fpage>12542</fpage>&#8211;<lpage>12547</lpage><pub-id pub-id-type="pmid">29109251</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1715363114</pub-id><pub-id pub-id-type="pmcid">PMC5703326</pub-id></mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Vardhana</surname><given-names>SA</given-names></name><etal/> (<year>2020</year>) <article-title>Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen</article-title>. <source>Nat. Immunol</source><volume>21</volume>, <fpage>1022</fpage>&#8211;<lpage>1033</lpage><pub-id pub-id-type="pmid">32661364</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-020-0725-2</pub-id><pub-id pub-id-type="pmcid">PMC7442749</pub-id></mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shi</surname><given-names>H</given-names></name><etal/> (<year>2024</year>) <article-title>Immunometabolism of CD8<sup>+</sup> T cell differentiation in cancer</article-title>. <source>Trends Cancer</source><volume>10</volume>, <fpage>610</fpage>&#8211;<lpage>626</lpage><pub-id pub-id-type="pmid">38693002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.trecan.2024.03.010</pub-id><pub-id pub-id-type="pmcid">PMC11342304</pub-id></mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ma</surname><given-names>S</given-names></name><etal/> (<year>2025</year>) <article-title>Targeting P4HA1 promotes CD8<sup>+</sup> T cell progenitor expansion toward immune memory and systemic antitumor immunity</article-title>. <source>Cancer Cell</source><volume>43</volume>, <fpage>213</fpage>&#8211;<lpage>231</lpage>.e219<pub-id pub-id-type="pmid">39729997</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ccell.2024.12.001</pub-id></mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yu</surname><given-names>Y-R</given-names></name><etal/> (<year>2020</year>) <article-title>Disturbed mitochondrial dynamics in CD8<sup>+</sup> TILs reinforce T cell exhaustion</article-title>. <source>Nat. Immunol</source><volume>21</volume>, <fpage>1540</fpage>&#8211;<lpage>1551</lpage><pub-id pub-id-type="pmid">33020660</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-020-0793-3</pub-id></mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><etal/> (<year>2023</year>) <article-title>Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1&#945;-mediated glycolytic reprogramming</article-title>. <source>Nat. Commun</source><volume>14</volume>, <fpage>6858</fpage><pub-id pub-id-type="pmid">37891230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-023-42634-3</pub-id><pub-id pub-id-type="pmcid">PMC10611730</pub-id></mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ma</surname><given-names>S</given-names></name><etal/> (<year>2025</year>) <article-title>Nutrient-driven histone code determines exhausted CD8<sup>+</sup> T cell fates</article-title>. <source>Science</source><volume>387</volume>, <fpage>eadj3020</fpage><pub-id pub-id-type="pmid">39666821</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.adj3020</pub-id><pub-id pub-id-type="pmcid">PMC11881194</pub-id></mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Simula</surname><given-names>L</given-names></name><etal/> (<year>2022</year>) <article-title>PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism</article-title>. <source>Mol. Oncol</source><volume>16</volume>, <fpage>188</fpage>&#8211;<lpage>205</lpage><pub-id pub-id-type="pmid">34535949</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1878-0261.13103</pub-id><pub-id pub-id-type="pmcid">PMC8732338</pub-id></mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Guo</surname><given-names>M</given-names></name><etal/> (<year>2023</year>) <article-title>Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control</article-title>. <source>Cell Rep</source><volume>42</volume>, <fpage>113047</fpage><pub-id pub-id-type="pmid">37651234</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2023.113047</pub-id><pub-id pub-id-type="pmcid">PMC10578141</pub-id></mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sinclair</surname><given-names>LV</given-names></name><etal/> (<year>2025</year>) <article-title>Autophagy repression by antigen and cytokines shapes mitochondrial, migration and effector machinery in CD8 Tcells</article-title>. <source>Nat. Immunol</source><volume>26</volume>, <fpage>429</fpage>&#8211;<lpage>443</lpage><pub-id pub-id-type="pmid">40016525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-025-02090-1</pub-id><pub-id pub-id-type="pmcid">PMC11876071</pub-id></mixed-citation></ref><ref id="R52"><label>52.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><etal/> (<year>2021</year>) <article-title>Autophagy in T-cell differentiation, survival and memory</article-title>. <source>Immunol. Cell Biol</source><volume>99</volume>, <fpage>351</fpage>&#8211;<lpage>360</lpage><pub-id pub-id-type="pmid">33141986</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/imcb.12422</pub-id></mixed-citation></ref><ref id="R53"><label>53.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><etal/> (<year>2014</year>) <article-title>Autophagy is essential for effector CD8+ T cell survival and memory formation</article-title>. <source>Nat. Immunol</source><volume>15</volume>, <fpage>1152</fpage>&#8211;<lpage>1161</lpage><pub-id pub-id-type="pmid">25362489</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3025</pub-id><pub-id pub-id-type="pmcid">PMC4232981</pub-id></mixed-citation></ref><ref id="R54"><label>54.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Vodnala</surname><given-names>SK</given-names></name><etal/> (<year>2019</year>) <article-title>T cell stemness and dysfunction in tumors are triggered by a common mechanism</article-title>. <source>Science</source><volume>363</volume>, <fpage>eaau0135</fpage><pub-id pub-id-type="pmid">30923193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aau0135</pub-id><pub-id pub-id-type="pmcid">PMC8194369</pub-id></mixed-citation></ref><ref id="R55"><label>55.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Devorkin</surname><given-names>L</given-names></name><etal/> (<year>2019</year>) <article-title>Autophagy regulation of metabolism is required for CD8+ T cell anti-tumor immunity</article-title>. <source>Cell Rep</source><volume>27</volume>, <fpage>502</fpage>&#8211;<lpage>513</lpage>.e505<pub-id pub-id-type="pmid">30970253</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2019.03.037</pub-id></mixed-citation></ref><ref id="R56"><label>56.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mocholi</surname><given-names>E</given-names></name><etal/> (<year>2018</year>) <article-title>Autophagy is a tolerance-avoidance mechanism that modulates TCR-mediated signaling and cell metabolism to prevent induction of T cell anergy</article-title>. <source>Cell Rep</source><volume>24</volume>, <fpage>1136</fpage>&#8211;<lpage>1150</lpage><pub-id pub-id-type="pmid">30067971</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2018.06.065</pub-id><pub-id pub-id-type="pmcid">PMC6109966</pub-id></mixed-citation></ref><ref id="R57"><label>57.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wei</surname><given-names>J</given-names></name><etal/> (<year>2016</year>) <article-title>Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis</article-title>. <source>Nat. Immunol</source><volume>17</volume>, <fpage>277</fpage>&#8211;<lpage>285</lpage><pub-id pub-id-type="pmid">26808230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3365</pub-id><pub-id pub-id-type="pmcid">PMC4755832</pub-id></mixed-citation></ref><ref id="R58"><label>58.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Feng</surname><given-names>P</given-names></name><etal/> (<year>2024</year>) <article-title>Vps34 sustains Treg cell survival and function via regulating intracellular redox homeostasis</article-title>. <source>Cell Death Differ</source><volume>31</volume>, <fpage>1519</fpage>&#8211;<lpage>1533</lpage><pub-id pub-id-type="pmid">39117783</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41418-024-01353-y</pub-id><pub-id pub-id-type="pmcid">PMC11519664</pub-id></mixed-citation></ref><ref id="R59"><label>59.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Norton</surname><given-names>EG</given-names></name><etal/> (<year>2025</year>) <article-title>Vps34-orchestrated lipid signaling processes regulate the transitional heterogeneity and functional adaptation of effector regulatory T cells</article-title>. <source>PLoS Biol</source><volume>23</volume>, <fpage>e3003074</fpage><pub-id pub-id-type="pmid">40215232</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pbio.3003074</pub-id><pub-id pub-id-type="pmcid">PMC11990774</pub-id></mixed-citation></ref><ref id="R60"><label>60.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><etal/> (<year>2018</year>) <article-title>Metabolic control of regulatory T cell stability and function by TRAF3IP3 at the lysosome</article-title>. <source>J. Exp. Med</source><volume>215</volume>, <fpage>2463</fpage>&#8211;<lpage>2476</lpage><pub-id pub-id-type="pmid">30115741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20180397</pub-id><pub-id pub-id-type="pmcid">PMC6122976</pub-id></mixed-citation></ref><ref id="R61"><label>61.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Valdor</surname><given-names>R</given-names></name><etal/> (<year>2014</year>) <article-title>Chaperone-mediated autophagy regulates T cell responses through targeted degradation of negative regulators of T cell activation</article-title>. <source>Nat. Immunol</source><volume>15</volume>, <fpage>1046</fpage>&#8211;<lpage>1054</lpage><pub-id pub-id-type="pmid">25263126</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3003</pub-id><pub-id pub-id-type="pmcid">PMC4208273</pub-id></mixed-citation></ref><ref id="R62"><label>62.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Whang</surname><given-names>MI</given-names></name><etal/> (<year>2017</year>) <article-title>The ubiquitin binding protein TAX1BP1 mediates autophagosome induction and the metabolic transition of activated T cells</article-title>. <source>Immunity</source><volume>46</volume>, <fpage>405</fpage>&#8211;<lpage>420</lpage><pub-id pub-id-type="pmid">28314591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2017.02.018</pub-id><pub-id pub-id-type="pmcid">PMC5400745</pub-id></mixed-citation></ref><ref id="R63"><label>63.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yu</surname><given-names>T</given-names></name><etal/> (<year>2023</year>) <article-title>TRIM11 attenuates Treg cell differentiation by p62-selective autophagic degradation of AIM2</article-title>. <source>Cell Rep</source><volume>42</volume>, <fpage>113231</fpage><pub-id pub-id-type="pmid">37804507</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2023.113231</pub-id></mixed-citation></ref><ref id="R64"><label>64.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gupta</surname><given-names>SS</given-names></name><etal/> (<year>2019</year>) <article-title>NIX-mediated mitophagy promotes effector memory formation in antigen-specific CD8<sup>+</sup> T cells</article-title>. <source>Cell Rep</source><volume>29</volume>, <fpage>1862</fpage>&#8211;<lpage>1877</lpage>.e1867<pub-id pub-id-type="pmid">31722203</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2019.10.032</pub-id><pub-id pub-id-type="pmcid">PMC6886713</pub-id></mixed-citation></ref><ref id="R65"><label>65.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Franco</surname><given-names>F</given-names></name><etal/> (<year>2023</year>) <article-title>Regulatory circuits of mitophagy restrict distinct modes of cell death during memory CD8+ T cell formation</article-title>. <source>Sci. Immunol</source><volume>8</volume>, <fpage>eadf7579</fpage><pub-id pub-id-type="pmid">37738363</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.adf7579</pub-id></mixed-citation></ref><ref id="R66"><label>66.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Swadling</surname><given-names>L</given-names></name><etal/> (<year>2020</year>) <article-title>Human liver memory CD8+ T cells use autophagy for tissue residence</article-title>. <source>Cell Rep</source><volume>30</volume>, <fpage>687</fpage>&#8211;<lpage>698</lpage>.e686<pub-id pub-id-type="pmid">31968246</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2019.12.050</pub-id><pub-id pub-id-type="pmcid">PMC6988113</pub-id></mixed-citation></ref><ref id="R67"><label>67.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lim</surname><given-names>SA</given-names></name><etal/> (<year>2022</year>) <article-title>Lipid metabolism in T cell signaling and function</article-title>. <source>Nat. Chem. Biol</source><volume>18</volume>, <fpage>470</fpage>&#8211;<lpage>481</lpage><pub-id pub-id-type="pmid">35484263</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41589-022-01017-3</pub-id><pub-id pub-id-type="pmcid">PMC11103273</pub-id></mixed-citation></ref><ref id="R68"><label>68.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nguyen</surname><given-names>HD</given-names></name><etal/> (<year>2020</year>) <article-title>Lysosomal acid lipase is required for donor T cells to induce graft-versus-host disease</article-title>. <source>Cell Rep</source><volume>33</volume>, <fpage>108316</fpage><pub-id pub-id-type="pmid">33113360</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2020.108316</pub-id><pub-id pub-id-type="pmcid">PMC7706352</pub-id></mixed-citation></ref><ref id="R69"><label>69.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Klein Geltink</surname><given-names>RI</given-names></name><etal/> (<year>2017</year>) <article-title>Mitochondrial priming by CD28</article-title>. <source>Cell</source><volume>171</volume>, <fpage>385</fpage>&#8211;<lpage>397</lpage>.e311<pub-id pub-id-type="pmid">28919076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2017.08.018</pub-id><pub-id pub-id-type="pmcid">PMC5637396</pub-id></mixed-citation></ref><ref id="R70"><label>70.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Menk</surname><given-names>AV</given-names></name><etal/> (<year>2018</year>) <article-title>4&#8211;1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses</article-title>. <source>J. Exp. Med</source><volume>215</volume>, <fpage>1091</fpage>&#8211;<lpage>1100</lpage><pub-id pub-id-type="pmid">29511066</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20171068</pub-id><pub-id pub-id-type="pmcid">PMC5881463</pub-id></mixed-citation></ref><ref id="R71"><label>71.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jackson</surname><given-names>CM</given-names></name><etal/> (<year>2024</year>) <article-title>The cytokine Meteorin-like inhibits anti-tumor CD8<sup>+</sup> T cell responses by disrupting mitochondrial function</article-title>. <source>Immunity</source><volume>57</volume>, <fpage>1864</fpage>&#8211;<lpage>1877</lpage>.e1869<pub-id pub-id-type="pmid">39111315</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2024.07.003</pub-id><pub-id pub-id-type="pmcid">PMC11324406</pub-id></mixed-citation></ref><ref id="R72"><label>72.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Valen&#231;a-Pereira</surname><given-names>F</given-names></name><etal/> (<year>2021</year>) <article-title>IL-6 enhances CD4 cell motility by sustaining mitochondrial Ca<sup>2+</sup> through the noncanonical STAT3 pathway</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source><volume>118</volume>, <fpage>e2103444118</fpage><pub-id pub-id-type="pmid">34507993</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2103444118</pub-id><pub-id pub-id-type="pmcid">PMC8449403</pub-id></mixed-citation></ref><ref id="R73"><label>73.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bishop</surname><given-names>EL</given-names></name><etal/> (<year>2024</year>) <article-title>TNF-&#945; signals through ITK-Akt-mTOR to drive CD4<sup>+</sup> T cell metabolic reprogramming, which is dysregulated in rheumatoid arthritis</article-title>. <source>Sci. Signal</source><volume>17</volume>, <fpage>eadg5678</fpage><pub-id pub-id-type="pmid">38652761</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scisignal.adg5678</pub-id></mixed-citation></ref><ref id="R74"><label>74.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Raynor</surname><given-names>JL</given-names></name> and <name name-style="western"><surname>Chi</surname><given-names>H</given-names></name> (<year>2024</year>) <article-title>Nutrients: signal 4 in T cell immunity</article-title>. <source>J. Exp. Med</source><volume>221</volume>, <fpage>e20221839</fpage><pub-id pub-id-type="pmid">38411744</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20221839</pub-id><pub-id pub-id-type="pmcid">PMC10899091</pub-id></mixed-citation></ref><ref id="R75"><label>75.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Long</surname><given-names>L</given-names></name><etal/> (<year>2021</year>) <article-title>CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity</article-title>. <source>Nature</source><volume>600</volume>, <fpage>308</fpage>&#8211;<lpage>313</lpage><pub-id pub-id-type="pmid">34795452</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-021-04109-7</pub-id><pub-id pub-id-type="pmcid">PMC8887674</pub-id></mixed-citation></ref><ref id="R76"><label>76.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>He</surname><given-names>J</given-names></name><etal/> (<year>2021</year>) <article-title>Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development</article-title>. <source>Nat. Commun</source><volume>12</volume>, <fpage>4371</fpage><pub-id pub-id-type="pmid">34272364</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-021-24619-2</pub-id><pub-id pub-id-type="pmcid">PMC8285428</pub-id></mixed-citation></ref><ref id="R77"><label>77.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shin</surname><given-names>HR</given-names></name><etal/> (<year>2022</year>) <article-title>Lysosomal GPCR-like protein LYCHOS signals cholesterol sufficiency to mTORC1</article-title>. <source>Science</source><volume>377</volume>, <fpage>1290</fpage>&#8211;<lpage>1298</lpage><pub-id pub-id-type="pmid">36007018</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.abg6621</pub-id><pub-id pub-id-type="pmcid">PMC10023259</pub-id></mixed-citation></ref><ref id="R78"><label>78.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Castellano</surname><given-names>BM</given-names></name><etal/> (<year>2017</year>) <article-title>Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex</article-title>. <source>Science</source><volume>355</volume>, <fpage>1306</fpage>&#8211;<lpage>1311</lpage><pub-id pub-id-type="pmid">28336668</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aag1417</pub-id><pub-id pub-id-type="pmcid">PMC5823611</pub-id></mixed-citation></ref><ref id="R79"><label>79.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Villa</surname><given-names>M</given-names></name><etal/> (<year>2024</year>) <article-title>Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment</article-title>. <source>Nat. Commun</source><volume>15</volume>, <fpage>451</fpage><pub-id pub-id-type="pmid">38200005</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-44689-2</pub-id><pub-id pub-id-type="pmcid">PMC10781727</pub-id></mixed-citation></ref><ref id="R80"><label>80.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cheng</surname><given-names>H</given-names></name><etal/> (<year>2023</year>) <article-title>Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness</article-title>. <source>Nat Metab</source><volume>5</volume>, <fpage>314</fpage>&#8211;<lpage>330</lpage><pub-id pub-id-type="pmid">36717749</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42255-022-00730-6</pub-id><pub-id pub-id-type="pmcid">PMC9970874</pub-id></mixed-citation></ref><ref id="R81"><label>81.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Scharping</surname><given-names>NE</given-names></name><etal/> (<year>2021</year>) <article-title>Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion</article-title>. <source>Nat. Immunol</source><volume>22</volume>, <fpage>205</fpage>&#8211;<lpage>215</lpage><pub-id pub-id-type="pmid">33398183</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-020-00834-9</pub-id><pub-id pub-id-type="pmcid">PMC7971090</pub-id></mixed-citation></ref><ref id="R82"><label>82.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><etal/> (<year>2023</year>) <article-title>Mitochondrial metabolic flexibility is critical for CD8<sup>+</sup> T cell antitumor immunity</article-title>. <source>Sci. Adv</source><volume>9</volume>, <fpage>eadf9522</fpage><pub-id pub-id-type="pmid">38055827</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciadv.adf9522</pub-id><pub-id pub-id-type="pmcid">PMC10699783</pub-id></mixed-citation></ref><ref id="R83"><label>83.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><etal/> (<year>2020</year>) <article-title>Inosine is an alternative carbon source for CD8<sup>+</sup>-T-cell function under glucose restriction</article-title>. <source>Nat. Metab</source><volume>2</volume>, <fpage>635</fpage>&#8211;<lpage>647</lpage><pub-id pub-id-type="pmid">32694789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42255-020-0219-4</pub-id><pub-id pub-id-type="pmcid">PMC7371628</pub-id></mixed-citation></ref><ref id="R84"><label>84.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hwang</surname><given-names>S-M</given-names></name><etal/> (<year>2024</year>) <article-title>Transgelin 2 guards T cell lipid metabolism and antitumour function</article-title>. <source>Nature</source><volume>635</volume>, <fpage>1010</fpage>&#8211;<lpage>1018</lpage><pub-id pub-id-type="pmid">39443795</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-024-08071-y</pub-id><pub-id pub-id-type="pmcid">PMC11949091</pub-id></mixed-citation></ref><ref id="R85"><label>85.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Feng</surname><given-names>Q</given-names></name><etal/> (<year>2022</year>) <article-title>Lactate increases stemness of CD8+ T cells to augment anti-tumor immunity</article-title>. <source>Nat. Commun</source><volume>13</volume>, <fpage>4981</fpage><pub-id pub-id-type="pmid">36068198</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-022-32521-8</pub-id><pub-id pub-id-type="pmcid">PMC9448806</pub-id></mixed-citation></ref><ref id="R86"><label>86.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Peralta</surname><given-names>RM</given-names></name><etal/> (<year>2024</year>) <article-title>Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism</article-title>. <source>Nat. Immunol</source><volume>25</volume>, <fpage>2297</fpage>&#8211;<lpage>2307</lpage><pub-id pub-id-type="pmid">39516648</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-024-01999-3</pub-id><pub-id pub-id-type="pmcid">PMC11588660</pub-id></mixed-citation></ref><ref id="R87"><label>87.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Elia</surname><given-names>I</given-names></name><etal/> (<year>2022</year>) <article-title>Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8<sup>+</sup> T cells</article-title>. <source>Cell Metab</source><volume>34</volume>, <fpage>1137</fpage>&#8211;<lpage>1150</lpage>.e1136<pub-id pub-id-type="pmid">35820416</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2022.06.008</pub-id><pub-id pub-id-type="pmcid">PMC9357162</pub-id></mixed-citation></ref><ref id="R88"><label>88.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Watson</surname><given-names>MJ</given-names></name><etal/> (<year>2021</year>) <article-title>Metabolic support of tumour-infiltrating regulatory T cells by lactic acid</article-title>. <source>Nature</source><volume>591</volume>, <fpage>645</fpage>&#8211;<lpage>651</lpage><pub-id pub-id-type="pmid">33589820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-020-03045-2</pub-id><pub-id pub-id-type="pmcid">PMC7990682</pub-id></mixed-citation></ref><ref id="R89"><label>89.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name><etal/> (<year>2024</year>) <article-title>Lactate supports Treg function and immune balance via MGAT1 effects on N-glycosylation in the mitochondria</article-title>. <source>J. Clin. Invest</source><volume>134</volume>, <fpage>e175897</fpage><pub-id pub-id-type="pmid">39264847</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI175897</pub-id><pub-id pub-id-type="pmcid">PMC11473165</pub-id></mixed-citation></ref><ref id="R90"><label>90.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shi</surname><given-names>H</given-names></name><etal/> (<year>2019</year>) <article-title>Amino acids license kinase mTORC1 activity and Treg cell function via small G proteins Rag and Rheb</article-title>. <source>Immunity</source><volume>51</volume>, <fpage>1012</fpage>&#8211;<lpage>1027</lpage>.e1017<pub-id pub-id-type="pmid">31668641</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2019.10.001</pub-id><pub-id pub-id-type="pmcid">PMC6948188</pub-id></mixed-citation></ref><ref id="R91"><label>91.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Do</surname><given-names>MH</given-names></name><etal/> (<year>2020</year>) <article-title>Nutrient mTORC1 signaling underpins regulatory T cell control of immune tolerance</article-title>. <source>J. Exp. Med</source><volume>217</volume>, <fpage>e20190848</fpage><pub-id pub-id-type="pmid">31649036</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20190848</pub-id><pub-id pub-id-type="pmcid">PMC7037250</pub-id></mixed-citation></ref><ref id="R92"><label>92.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ham</surname><given-names>H</given-names></name><etal/> (<year>2025</year>) <article-title>Lysosomal NKG7 restrains mTORC1 activity to promote CD8<sup>+</sup> T cell durability and tumor control</article-title>. <source>Nat. Commun</source><volume>16</volume>, <fpage>1628</fpage><pub-id pub-id-type="pmid">39952956</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-025-56931-6</pub-id><pub-id pub-id-type="pmcid">PMC11829009</pub-id></mixed-citation></ref><ref id="R93"><label>93.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lepez</surname><given-names>A</given-names></name><etal/> (<year>2020</year>) <article-title>Long-term T cell fitness and proliferation is driven by AMPK-dependent regulation of reactive oxygen species</article-title>. <source>Sci. Rep</source><volume>10</volume>, <fpage>21673</fpage><pub-id pub-id-type="pmid">33303820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-020-78715-2</pub-id><pub-id pub-id-type="pmcid">PMC7728748</pub-id></mixed-citation></ref><ref id="R94"><label>94.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Blagih</surname><given-names>J</given-names></name><etal/> (<year>2015</year>) <article-title>The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo</article-title>. <source>Immunity</source><volume>42</volume>, <fpage>41</fpage>&#8211;<lpage>54</lpage><pub-id pub-id-type="pmid">25607458</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2014.12.030</pub-id></mixed-citation></ref><ref id="R95"><label>95.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Baixauli</surname><given-names>F</given-names></name><etal/> (<year>2015</year>) <article-title>Mitochondrial respiration controls lysosomal function during inflammatory T cell responses</article-title>. <source>Cell Metab</source><volume>22</volume>, <fpage>485</fpage>&#8211;<lpage>498</lpage><pub-id pub-id-type="pmid">26299452</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2015.07.020</pub-id><pub-id pub-id-type="pmcid">PMC5026297</pub-id></mixed-citation></ref><ref id="R96"><label>96.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Desd&#237;n-Mic&#243;</surname><given-names>G</given-names></name><etal/> (<year>2020</year>) <article-title>T cells with dysfunctional mitochondria induce multimorbidity and premature senescence</article-title>. <source>Science</source><volume>368</volume>, <fpage>1371</fpage>&#8211;<lpage>1376</lpage><pub-id pub-id-type="pmid">32439659</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aax0860</pub-id><pub-id pub-id-type="pmcid">PMC7616968</pub-id></mixed-citation></ref><ref id="R97"><label>97.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Joulia</surname><given-names>E</given-names></name><etal/> (<year>2024</year>) <article-title>Eomes-dependent mitochondrial regulation promotes survival of pathogenic CD4<sup>+</sup> T cells during inflammation</article-title>. <source>J. Exp. Med</source><volume>221</volume>, <fpage>e20230449</fpage><pub-id pub-id-type="pmid">38189779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20230449</pub-id><pub-id pub-id-type="pmcid">PMC10772920</pub-id></mixed-citation></ref><ref id="R98"><label>98.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kaymak</surname><given-names>I</given-names></name><etal/> (<year>2024</year>) <article-title>ACLY and ACSS2 link nutrient-dependent chromatin accessibility to CD8 T cell effector responses</article-title>. <source>J. Exp. Med</source><volume>221</volume>, <fpage>e20231820</fpage><pub-id pub-id-type="pmid">39150482</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20231820</pub-id><pub-id pub-id-type="pmcid">PMC11329787</pub-id></mixed-citation></ref><ref id="R99"><label>99.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><etal/> (<year>2019</year>) <article-title>The transcription factor Bhlhe40 programs mitochondrial regulation of resident CD8<sup>+</sup> T cell fitness and functionality</article-title>. <source>Immunity</source><volume>51</volume>, <fpage>491</fpage>&#8211;<lpage>507</lpage>.e497<pub-id pub-id-type="pmid">31533057</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2019.08.013</pub-id><pub-id pub-id-type="pmcid">PMC6903704</pub-id></mixed-citation></ref><ref id="R100"><label>100.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hochrein</surname><given-names>SM</given-names></name><etal/> (<year>2022</year>) <article-title>The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming</article-title>. <source>Cell Metab</source><volume>34</volume>, <fpage>516</fpage>&#8211;<lpage>532</lpage>.e511<pub-id pub-id-type="pmid">35316657</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2022.02.015</pub-id><pub-id pub-id-type="pmcid">PMC9019065</pub-id></mixed-citation></ref><ref id="R101"><label>101.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wagner</surname><given-names>A</given-names></name><etal/> (<year>2021</year>) <article-title>Metabolic modeling of single Th17 cells reveals regulators of autoimmunity</article-title>. <source>Cell</source><volume>184</volume>, <fpage>4168</fpage>&#8211;<lpage>4185</lpage>.e4121<pub-id pub-id-type="pmid">34216539</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2021.05.045</pub-id><pub-id pub-id-type="pmcid">PMC8621950</pub-id></mixed-citation></ref><ref id="R102"><label>102.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Puleston</surname><given-names>DJ</given-names></name><etal/> (<year>2021</year>) <article-title>Polyamine metabolism is a central determinant of helper T cell lineage fidelity</article-title>. <source>Cell</source><volume>184</volume>, <fpage>4186</fpage>&#8211;<lpage>4202</lpage>.e4120<pub-id pub-id-type="pmid">34216540</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2021.06.007</pub-id><pub-id pub-id-type="pmcid">PMC8358979</pub-id></mixed-citation></ref><ref id="R103"><label>103.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Xia</surname><given-names>M</given-names></name><etal/> (<year>2022</year>) <article-title>Transcription factor EB coordinates environmental cues to regulate T regulatory cells&#8217; mitochondrial fitness and function</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source><volume>119</volume>, <fpage>e2205469119</fpage><pub-id pub-id-type="pmid">35895684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2205469119</pub-id><pub-id pub-id-type="pmcid">PMC9351480</pub-id></mixed-citation></ref><ref id="R104"><label>104.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><etal/> (<year>2023</year>) <article-title>SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity</article-title>. <source>Nature</source><volume>620</volume>, <fpage>200</fpage>&#8211;<lpage>208</lpage><pub-id pub-id-type="pmid">37407815</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-023-06299-8</pub-id><pub-id pub-id-type="pmcid">PMC10396969</pub-id></mixed-citation></ref><ref id="R105"><label>105.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><etal/> (<year>2024</year>) <article-title>Lithium carbonate revitalizes tumor-reactive CD8<sup>+</sup> T cells by shunting lactic acid into mitochondria</article-title>. <source>Nat. Immunol</source><volume>25</volume>, <fpage>552</fpage>&#8211;<lpage>561</lpage><pub-id pub-id-type="pmid">38263463</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-023-01738-0</pub-id><pub-id pub-id-type="pmcid">PMC10907288</pub-id></mixed-citation></ref><ref id="R106"><label>106.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Xu</surname><given-names>C</given-names></name><etal/> (<year>2020</year>) <article-title>SIRT1 is downregulated by autophagy in senescence and ageing</article-title>. <source>Nat. Cell Biol</source><volume>22</volume>, <fpage>1170</fpage>&#8211;<lpage>1179</lpage><pub-id pub-id-type="pmid">32989246</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41556-020-00579-5</pub-id><pub-id pub-id-type="pmcid">PMC7805578</pub-id></mixed-citation></ref><ref id="R107"><label>107.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhao</surname><given-names>F</given-names></name><etal/> (<year>2024</year>) <article-title>GRP75-dependent mitochondria-ER contacts ensure cell survival during early mouse thymocyte development</article-title>. <source>Dev. Cell</source><volume>59</volume>, <fpage>2643</fpage>&#8211;<lpage>2658</lpage>.e2647<pub-id pub-id-type="pmid">38981469</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.devcel.2024.06.007</pub-id></mixed-citation></ref><ref id="R108"><label>108.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ho</surname><given-names>P-C</given-names></name><etal/> (<year>2015</year>) <article-title>Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses</article-title>. <source>Cell</source><volume>162</volume>, <fpage>1217</fpage>&#8211;<lpage>1228</lpage><pub-id pub-id-type="pmid">26321681</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2015.08.012</pub-id><pub-id pub-id-type="pmcid">PMC4567953</pub-id></mixed-citation></ref><ref id="R109"><label>109.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yang</surname><given-names>JF</given-names></name><etal/> (<year>2023</year>) <article-title>Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8<sup>+</sup> T cell metabolic fitness and function in tumors</article-title>. <source>Sci. Immunol</source><volume>8</volume>, <fpage>eabq2424</fpage><pub-id pub-id-type="pmid">37738362</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.abq2424</pub-id></mixed-citation></ref><ref id="R110"><label>110.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nava Lauson</surname><given-names>CB</given-names></name><etal/> (<year>2023</year>) <article-title>Linoleic acid potentiates CD8<sup>+</sup> T cell metabolic fitness and antitumor immunity</article-title>. <source>Cell Metab</source><volume>35</volume>, <fpage>633</fpage>&#8211;<lpage>650</lpage>.e639<pub-id pub-id-type="pmid">36898381</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2023.02.013</pub-id></mixed-citation></ref><ref id="R111"><label>111.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><etal/> (<year>2023</year>) <article-title>VMP1 prevents Ca<sup>2+</sup> overload in endoplasmic reticulum and maintains naive T cell survival</article-title>. <source>J. Exp. Med</source><volume>220</volume>, <fpage>e20221068</fpage><pub-id pub-id-type="pmid">36971758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20221068</pub-id><pub-id pub-id-type="pmcid">PMC10060355</pub-id></mixed-citation></ref><ref id="R112"><label>112.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Clement</surname><given-names>D</given-names></name><etal/> (<year>2023</year>) <article-title>The lysosomal calcium channel TRPML1 maintains mitochondrial fitness in NK cells through interorganelle cross-talk</article-title>. <source>J. Immunol</source><volume>211</volume>, <fpage>1348</fpage>&#8211;<lpage>1358</lpage><pub-id pub-id-type="pmid">37737664</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.2300406</pub-id><pub-id pub-id-type="pmcid">PMC10579149</pub-id></mixed-citation></ref><ref id="R113"><label>113.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zurli</surname><given-names>V</given-names></name><etal/> (<year>2020</year>) <article-title>Phosphoproteomics of CD2 signaling reveals AMPK-dependent regulation of lytic granule polarization in cytotoxic T cells</article-title>. <source>Sci. Signal</source>. <volume>13</volume>, <fpage>eaaz1965</fpage><pub-id pub-id-type="pmid">32398348</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scisignal.aaz1965</pub-id></mixed-citation></ref><ref id="R114"><label>114.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Deus</surname><given-names>CM</given-names></name><etal/> (<year>2020</year>) <article-title>Mitochondria&#8211;lysosome crosstalk: from physiology to neurodegeneration</article-title>. <source>Trends Mol. Med</source><volume>26</volume>, <fpage>71</fpage>&#8211;<lpage>88</lpage><pub-id pub-id-type="pmid">31791731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molmed.2019.10.009</pub-id></mixed-citation></ref><ref id="R115"><label>115.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Schlie</surname><given-names>K</given-names></name><etal/> (<year>2015</year>) <article-title>Survival of effector CD8<sup>+</sup> T cells during influenza infection is dependent on autophagy</article-title>. <source>J. Immunol</source><volume>194</volume>, <fpage>4277</fpage>&#8211;<lpage>4286</lpage><pub-id pub-id-type="pmid">25833396</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1402571</pub-id></mixed-citation></ref><ref id="R116"><label>116.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bonetti</surname><given-names>L</given-names></name><etal/> (<year>2024</year>) <article-title>A Th17 cell-intrinsic glutathione/mitochondrial-IL-22 axis protects against intestinal inflammation</article-title>. <source>Cell Metab</source><volume>36</volume>, <fpage>1726</fpage>&#8211;<lpage>1744</lpage>.e1710<pub-id pub-id-type="pmid">38986617</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2024.06.010</pub-id></mixed-citation></ref><ref id="R117"><label>117.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>D</given-names></name><etal/> (<year>2021</year>) <article-title>Fever supports CD8<sup>+</sup> effector T cell responses by promoting mitochondrial translation</article-title>. <source>proc. Natl. Acad. Sci. U. S. A</source><volume>118</volume>, <fpage>e2023752118</fpage><pub-id pub-id-type="pmid">34161266</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2023752118</pub-id><pub-id pub-id-type="pmcid">PMC8237659</pub-id></mixed-citation></ref><ref id="R118"><label>118.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zebley</surname><given-names>CC</given-names></name><etal/> (<year>2024</year>) <article-title>T cell dysfunction and therapeutic intervention in cancer</article-title>. <source>Nat. Immunol</source><volume>25</volume>, <fpage>1344</fpage>&#8211;<lpage>1354</lpage><pub-id pub-id-type="pmid">39025962</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-024-01896-9</pub-id><pub-id pub-id-type="pmcid">PMC11616736</pub-id></mixed-citation></ref><ref id="R119"><label>119.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yardeni</surname><given-names>T</given-names></name><etal/> (<year>2025</year>) <article-title>Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source><volume>122</volume>, <fpage>e2417252121</fpage><pub-id pub-id-type="pmid">39752523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2417252121</pub-id><pub-id pub-id-type="pmcid">PMC11725793</pub-id></mixed-citation></ref><ref id="R120"><label>120.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Abad</surname><given-names>C</given-names></name><etal/> (<year>2024</year>) <article-title>IFN&#947; causes mitochondrial dysfunction and oxidative stress in myositis</article-title>. <source>Nat. Commun</source><volume>15</volume>, <fpage>5403</fpage><pub-id pub-id-type="pmid">38926363</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-49460-1</pub-id><pub-id pub-id-type="pmcid">PMC11208592</pub-id></mixed-citation></ref><ref id="R121"><label>121.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Alissafi</surname><given-names>T</given-names></name><etal/> (<year>2020</year>) <article-title>Mitochondrial oxidative damage underlies regulatory T cell defects in autoimmunity</article-title>. <source>Cell Metab</source><volume>32</volume>, <fpage>591</fpage>&#8211;<lpage>604</lpage>.e597<pub-id pub-id-type="pmid">32738205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2020.07.001</pub-id><pub-id pub-id-type="pmcid">PMC7611060</pub-id></mixed-citation></ref><ref id="R122"><label>122.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Patterson</surname><given-names>AR</given-names></name><etal/> (<year>2024</year>) <article-title>Functional overlap of inborn errors of immunity and metabolism genes defines T cell metabolic vulnerabilities</article-title>. <source>Sci. Immunol</source><volume>9</volume>, <fpage>eadh0368</fpage><pub-id pub-id-type="pmid">39151020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.adh0368</pub-id><pub-id pub-id-type="pmcid">PMC11590014</pub-id></mixed-citation></ref><ref id="R123"><label>123.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shi</surname><given-names>H</given-names></name><etal/> (<year>2022</year>) <article-title>CRISPR screens for functional interrogation of immunity</article-title>. <source>Nat. Rev. Immunol</source><volume>23</volume>, <fpage>363</fpage>&#8211;<lpage>380</lpage><pub-id pub-id-type="pmid">36481809</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41577-022-00802-4</pub-id></mixed-citation></ref><ref id="R124"><label>124.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhou</surname><given-names>P</given-names></name><etal/> (<year>2023</year>) <article-title>Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer</article-title>. <source>Nature</source><volume>624</volume>, <fpage>154</fpage>&#8211;<lpage>163</lpage><pub-id pub-id-type="pmid">37968405</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-023-06733-x</pub-id><pub-id pub-id-type="pmcid">PMC10700132</pub-id></mixed-citation></ref><ref id="R125"><label>125.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Pretto</surname><given-names>S</given-names></name><etal/> (<year>2025</year>) <article-title>A functional single-cell metabolic survey identifies Elovl1 as a target to enhance CD8<sup>+</sup> T cell fitness in solid tumours</article-title>. <source>Nat. Metab</source><volume>7</volume>, <fpage>508</fpage>&#8211;<lpage>530</lpage><pub-id pub-id-type="pmid">40065102</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42255-025-01233-w</pub-id><pub-id pub-id-type="pmcid">PMC11946891</pub-id></mixed-citation></ref><ref id="R126"><label>126.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chen</surname><given-names>KY</given-names></name><etal/> (<year>2025</year>) <article-title>Genome-wide CRISPR screen in human T cells reveals regulators of FOXP3</article-title>. <source>Nature</source><volume>642</volume>, <fpage>191</fpage>&#8211;<lpage>200</lpage><pub-id pub-id-type="pmid">40140585</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-025-08795-5</pub-id></mixed-citation></ref><ref id="R127"><label>127.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Arg&#252;ello</surname><given-names>RJ</given-names></name><etal/> (<year>2020</year>) <article-title>SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution</article-title>. <source>Cell Metab</source><volume>32</volume>, <fpage>1063</fpage>&#8211;<lpage>1075</lpage>.e1067<pub-id pub-id-type="pmid">33264598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2020.11.007</pub-id><pub-id pub-id-type="pmcid">PMC8407169</pub-id></mixed-citation></ref><ref id="R128"><label>128.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/> (<year>2024</year>) <article-title>A fluorogenic complementation tool kit for interrogating lipid droplet&#8211;organelle interaction</article-title>. <source>J. Cell Biol</source><volume>223</volume>, <fpage>e202311126</fpage><pub-id pub-id-type="pmid">38949658</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.202311126</pub-id><pub-id pub-id-type="pmcid">PMC11215687</pub-id></mixed-citation></ref><ref id="R129"><label>129.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Baldwin</surname><given-names>JG</given-names></name><etal/> (<year>2024</year>) <article-title>Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy</article-title>. <source>Cell</source><volume>187</volume>, <fpage>6614</fpage>&#8211;<lpage>6630</lpage>.e6621<pub-id pub-id-type="pmid">39276774</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2024.08.029</pub-id><pub-id pub-id-type="pmcid">PMC11623344</pub-id></mixed-citation></ref><ref id="R130"><label>130.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Saha</surname><given-names>T</given-names></name><etal/> (<year>2022</year>) <article-title>Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells</article-title>. <source>Nat. Nanotechnol</source><volume>17</volume>, <fpage>98</fpage>&#8211;<lpage>106</lpage><pub-id pub-id-type="pmid">34795441</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41565-021-01000-4</pub-id><pub-id pub-id-type="pmcid">PMC10071558</pub-id></mixed-citation></ref><ref id="R131"><label>131.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ikeda</surname><given-names>H</given-names></name><etal/> (<year>2025</year>) <article-title>Immune evasion through mitochondrial transfer in the tumour microenvironment</article-title>. <source>Nature</source><volume>638</volume>, <fpage>225</fpage>&#8211;<lpage>236</lpage><pub-id pub-id-type="pmid">39843734</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-024-08439-0</pub-id><pub-id pub-id-type="pmcid">PMC11798832</pub-id></mixed-citation></ref><ref id="R132"><label>132.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Headley</surname><given-names>CA</given-names></name><etal/> (<year>2024</year>) <article-title>Extracellular delivery of functional mitochondria rescues the dysfunction of CD4<sup>+</sup> T cells in aging</article-title>. <source>Adv. Sci</source><volume>11</volume>, <fpage>e2303664</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/advs.202303664</pub-id><pub-id pub-id-type="pmcid">PMC10837346</pub-id><pub-id pub-id-type="pmid">37990641</pub-id></mixed-citation></ref><ref id="R133"><label>133.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Headley</surname><given-names>CA</given-names></name><etal/> (<year>2024</year>) <article-title>Mitochondrial transplantation promotes protective effector and memory CD4+ T cell response during Mycobacterium tuberculosis infection and diminishes exhaustion and senescence in elderly CD4+ T cells</article-title>. <source>Adv. Sci</source><volume>11</volume>, <fpage>e2401077</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/advs.202401077</pub-id><pub-id pub-id-type="pmcid">PMC11423092</pub-id><pub-id pub-id-type="pmid">39039808</pub-id></mixed-citation></ref><ref id="R134"><label>134.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Court</surname><given-names>AC</given-names></name><etal/> (<year>2024</year>) <article-title>Survival advantage of native and engineered T cells is acquired by mitochondrial transfer from mesenchymal stem cells</article-title>. <source>J. Transl. Med</source><volume>22</volume>, <fpage>868</fpage><pub-id pub-id-type="pmid">39334383</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-024-05627-4</pub-id><pub-id pub-id-type="pmcid">PMC11429672</pub-id></mixed-citation></ref><ref id="R135"><label>135.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Court</surname><given-names>AC</given-names></name><etal/> (<year>2020</year>) <article-title>Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response</article-title>. <source>EMBO Rep</source><volume>21</volume>, <fpage>e48052</fpage><pub-id pub-id-type="pmid">31984629</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embr.201948052</pub-id><pub-id pub-id-type="pmcid">PMC7001501</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1" orientation="portrait"><label>Figure 1.</label><caption><p id="P52">Signals 1&#8211;4 regulate T cell functional adaptation and instigate mitochondria-and lysosome-dependent metabolic reprogramming. Signals 1 (TCR binding to cognate antigen), 2 (co-stimulation; e.g., CD28 or 4&#8211;1BB), and 3 (cytokines; e.g., IL-2, IL-6, or IL-15) tune nutrient-dependent Signal 4 by altering the expression of nutrient transporters. Signal 4 reciprocally regulates Signals 1&#8211;3 by altering metabolic and signaling pathways. Together, these extracellular cues influence mitochondrial and lysosomal functions to induce metabolic rewiring and signaling events that support T cell functional adaptation in response to microenvironmental cues. Organelle crosstalk (e.g., between mitochondria and lysosomes) further supports metabolic reprogramming and context-specific functions.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-2100613-f0001.jpg"/></fig><fig position="float" id="F2" orientation="portrait"><label>Figure 2.</label><caption><title>Mitochondrial metabolism influences T cell fate and function.</title><p id="P53">(A) Oxidative phosphorylation (OXPHOS) and glycolysis are differentially regulated throughout thymic development. &#945;&#946; T cells have increased OXPHOS over glycolysis at the double-negative 3 (DN3) stage, accompanied by mTORC1 activation and MYC expression. mTORC1 and MYC reciprocally activate one another to facilitate &#945;&#946; T cell lineage commitment and inhibit &#947;&#948; T cell differentiation. Mitochondrial pyruvate oxidation (mediated by mitochondrial pyruvate carrier; MPC1) is required at the &#946;-selection, immature single-positive (ISP)-SP transition, and positive selection stages of development. (B) The electron transport chain (ETC) is essential for CD4<sup>+</sup> T cell activation, effector function, and survival as indicated. Various inhibitors of ETC function are depicted. (C) Mitochondrial metabolism and dynamics regulate CD8<sup>+</sup> T cell programming. Mitochondrial protein translation generates ETC components that are required to establish mitochondrial membrane potential (MMP) and effector T (T<sub>EFF</sub>) cell cytotoxic function. MMP induces reactive oxygen species (ROS) and is negatively regulated by MCJ, an inhibitor of ETC Complex I. MMP and ROS levels coordinate memory T (T<sub>MEM</sub>) versus T<sub>EFF</sub> responses, as decreased MMP/ROS promotes long-term T<sub>MEM</sub> survival and quiescence by reducing oxidative stress, while increased MMP/ROS promotes T<sub>EFF</sub> activation downstream of TCR stimulation. Opa1-mediated mitochondrial fusion increases OXPHOS to enhance T<sub>MEM</sub> generation, while Drp1-mediated mitochondrial fission increases glycolysis for T<sub>EFF</sub> cells. (D) Oxidative metabolism maintains regulatory T (Treg) cell functional fitness. TFAM induces mitochondrial gene expression that supports the synthesis of ETC components, while LKB1 and mTORC1 signaling promotes mitochondrial metabolism that fuels ETC function. Together with MYC activity, these processes increase OXPHOS and promote effector Treg (eTreg) cell activation to induce the expression of eTreg suppressive molecules (e.g., ICOS, CTLA-4, KLRG1, and IL-10).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-2100613-f0002.jpg"/></fig><fig position="float" id="F3" orientation="portrait"><label>Figure 3.</label><caption><title>Autophagy is differentially regulated in T cell subsets.</title><p id="P54">(A) Na&#239;ve T (T<sub>NAIVE</sub>) cells have increased autophagy flux that supports their survival and homeostasis. Upper: increased clearance of damaged mitochondria via Parkin- and Nix-mediated mitophagy enhances expression of antiapoptotic MCL-1, promoting T<sub>NAIVE</sub> survival and homeostasis. Lower: increased autophagy flux increases the generation of nutrients to support protein synthesis, including the adhesion receptor CD62L that supports T<sub>NAIVE</sub> trafficking in lymphoid tissues. (B) Lysosomal metabolism regulates memory T (T<sub>MEM</sub>) cell generation. T<sub>MEM</sub> cells have increased autophagy flux and lipolysis mediated by lysosomal acid lipase (LAL), which both generate substrates for mitochondrial oxidative phosphorylation (OXPHOS), enhancing T<sub>MEM</sub> recall responses and survival. Parkin- and Nix-mediated mitophagy inhibits apoptosis or ferroptosis and induces the recycling of mitochondrial metabolites to generate long-chain fatty acids (LCFAs) that are used as an energy source to promote effector memory T (T<sub>EM</sub>) cell generation. Nutrient-replete conditions suppress the activation of transcription factor TFEB that promotes lysosome biogenesis and CCR9-mediated trafficking of CD8<sup>+</sup> T cells to the small intestine. (C) Lysosome-mediated metabolism promotes effector regulatory T (eTreg) cell function. TRAFIP3-mediated mTORC1 inhibition at the lysosome promotes autophagy flux, enhancing oxidative metabolism that supports eTreg maintenance and suppressive function. mTORC1 signaling negatively regulates autophagy and promotes glycolytic metabolism, which can impair <italic toggle="yes">Foxp3</italic> expression and compromise Treg lineage stability. (D) Effector T (T<sub>EFF</sub>) cells maintain their activation status via selective autophagy. Selective autophagy, mediated by chaperone proteins such as TAX1BP1, promotes the degradation of Itch and RCAN1. Substrate degradation increases the generation of nutrients like L-cysteine that activate mTORC1 signaling and promote glycolytic metabolism, increasing T<sub>EFF</sub> proliferation and survival.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-2100613-f0003.jpg"/></fig><fig position="float" id="F4" orientation="portrait"><label>Figure 4.</label><caption><title>Mitochondria and lysosomes are signaling platforms in T cells.</title><p id="P55">(A) Lysosome-associated signaling coordinates nutrient cues and metabolic reprogramming. Nutrient-replete environments activate mTORC1-mediated anabolic metabolism via the lysosome-associated small G proteins RagA/B and Rheb and inhibit catabolic metabolism initiated by AMPK. Flcn and RagA/B inhibit TFEB-mediated lysosomal biogenesis under nutrient-replete conditions, while TFAM-dependent oxidative phosphorylation (OXPHOS) negatively regulates TFEB to maintain metabolic homeostasis. (B) Mitochondria-associated signaling processes regulate T cell transcriptional and epigenetic reprogramming. Mitochondrial reactive oxygen species (mROS), a byproduct of OXPHOS, activate the transcription factor NFAT to coordinate T cell activation and differentiation. Citrate-derived acetyl-CoA (generated by ACLY) promotes histone acetylation, while one-carbon (1C) metabolism mediated by MTHFD2 induces S-adenosylmethionine (SAM) expression that coordinates histone methylation. (C) Mitochondria-ER crosstalk is mediated by membrane contact sites called MERCs, which regulate calcium (Ca<sup>2+</sup>) influx into the mitochondria. MERCs are mediated by different molecules according to developmental stage. GRP75 bridges IP3R (ER) and VDAC1 (mitochondria) interactions to promote the transition of DN3 to DN4 thymocytes in the thymus, while SERCA2 (ER) and MFN2 (mitochondria) enhance the proliferation and cytotoxicity of T<sub>EFF</sub> cells in the periphery. VMP1 mediates store-operated calcium entry (SOCE) to prevent calcium overload in the mitochondria or the ER, thereby limiting calcium-induced mitochondria and ER stress.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-2100613-f0004.jpg"/></fig><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1.</label><caption><p id="P56">Targeting mitochondria and lysosomes in immune-mediated diseases<sup><xref rid="TFN1" ref-type="table-fn">a</xref></sup></p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Therapeutic target</th><th align="left" valign="top" rowspan="1" colspan="1">Metabolic effect</th><th align="left" valign="top" rowspan="1" colspan="1">Cell types</th><th align="left" valign="top" rowspan="1" colspan="1">Functional effect</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">MCJ</td><td align="left" valign="top" rowspan="1" colspan="1">Increased mitochondrial membrane potential</td><td align="left" valign="top" rowspan="1" colspan="1">Effector CD8<sup>+</sup> T cell CD19 CAR-T cell</td><td align="left" valign="top" rowspan="1" colspan="1">Enhanced antitumor immunity or viral control due to increased secretion of IFN-&#947;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PD-1</td><td align="left" valign="top" rowspan="1" colspan="1">Increased mitochondrial fission</td><td align="left" valign="top" rowspan="1" colspan="1">Intratumoral CD8<sup>+</sup> T cell</td><td align="left" valign="top" rowspan="1" colspan="1">Enhanced antitumor immunity due to increased Drp1-dependent fission-mediated proliferation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CTLA-4</td><td align="left" valign="top" rowspan="1" colspan="1">Decreased mitochondrial OXPHOS</td><td align="left" valign="top" rowspan="1" colspan="1">Intratumoral CD4<sup>+</sup> T cell</td><td align="left" valign="top" rowspan="1" colspan="1">Enhanced antitumor immunity due to increased proliferation and migration</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Atg5</td><td align="left" valign="top" rowspan="1" colspan="1">Decreased autophagy flux</td><td align="left" valign="top" rowspan="1" colspan="1">Intratumoral CD8<sup>+</sup> T cell</td><td align="left" valign="top" rowspan="1" colspan="1">Enhanced antitumor immunity due to increased generation of effector/memory cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Atg5<break/>Atg7<break/>Atg14<break/>Vps34</td><td align="left" valign="top" rowspan="1" colspan="1">Decreased autophagy flux</td><td align="left" valign="top" rowspan="1" colspan="1">Intratumoral CD8<sup>+</sup> T cell</td><td align="left" valign="top" rowspan="1" colspan="1">Enhanced antitumor immunity due to decreased accumulation of intratumoral Tregs</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Flcn</td><td align="left" valign="top" rowspan="1" colspan="1">Increased lysosome biogenesis</td><td align="left" valign="top" rowspan="1" colspan="1">CD8<sup>+</sup> T<sub>RM</sub> cell</td><td align="left" valign="top" rowspan="1" colspan="1">Enhanced control of intestinal infections due to increased migration and differentiation</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>a</label><p id="P57">Targeting mitochondria or lysosome function in T cells has therapeutic potential for the treatment of infectious disease, tumors, autoimmunity, and metabolic disorders. The table provides a summary of potential therapeutic interventions, including the molecular and cellular targets.</p></fn></table-wrap-foot></table-wrap><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Highlights</title></caption><p id="P58">Organelles, especially mitochondria and lysosomes, are crucial hubs orchestrating the metabolic fate and functional adaptation of T cells in response to different inflammatory insults or tissue microenvironments.</p><p id="P59">Beyond their bioenergetic and degradative functions, mitochondria and lysosomes coordinate extracellular and intracellular signaling cues to orchestrate T cell-mediated adaptive immunity.</p><p id="P60">Mitochondria and lysosomes regulate cell fate decisions via organelle crosstalk, and dysregulation of either mitochondrial or lysosomal fitness is frequently associated with dysfunction in the other organelle.</p><p id="P61">Aberrant mitochondrial or lysosomal function contributes to immune-mediated diseases and is a potential target for therapeutic intervention.</p></boxed-text><boxed-text id="BX2" position="float" orientation="portrait"><caption><title>Significance</title></caption><p id="P62">Cellular metabolism is a key regulator of T cell-mediated adaptive immunity. As central hubs for bioenergetic and biosynthetic reactions, mitochondria and lysosomes support T cell functional adaptation. These organelles also coordinate signaling processes that establish transcriptional and epigenetic programs in T cells, thereby contributing to adaptive immune responses. Therefore, tuning mitochondrial or lysosomal activity is a promising intervention to bolster T cell fitness or restore cellular homeostasis.</p></boxed-text><boxed-text id="BX3" position="float" orientation="portrait"><caption><title>Outstanding questions</title></caption><p id="P63">Can we target mitochondria- or lysosome-related metabolic and signaling processes to rewire T cell function in cancer and immune-mediated diseases?</p><p id="P64">What are the signaling mechanisms mediating mitochondrial or lysosomal function in T cell biology?</p><p id="P65">Do functional mitochondria&#8211;lysosome membrane contact sites orchestrate T cell responses, and how is the organelle crosstalk regulated?</p><p id="P66">Beyond mitochondria, are other organelles such as lysosomes transferred between T cells and other cell types? If so, what are the functional consequences?</p></boxed-text><boxed-text id="BX4" position="float" orientation="portrait"><caption><title>Box 1. Intercellular mitochondrial transfer and T cell function</title></caption><p id="P67">Recent work has shown that intercellular mitochondrial transfer can reinvigorate or hamper cellular metabolism and function in a context-dependent manner. Protrusions of F-actin, termed tunneling nanotubes (TNTs), mediate the transfer of mitochondria to and from T cells. The functional impact of intercellular mitochondria exchange is dependent on the direction of organelle transfer and the source of donor mitochondria. Talin-2-mediated mitochondrial transfer from bone marrow stromal cells invigorates CD8<sup>+</sup> T cell cytotoxicity against mouse models of solid and hematological cancers [<xref rid="R129" ref-type="bibr">129</xref>], while Miro1-mediated transfer of mitochondria from CD8<sup>+</sup> T cells to cancer cells augments cancer cell respiration and impairs T cell function [<xref rid="R130" ref-type="bibr">130</xref>]. Mitochondrial transfer has translational relevance, both for inhibiting cancer cell-mediated metabolic dysfunction in T cells and for reinvigorating aged, senescent T cells (<xref rid="F5" ref-type="fig">Figure I</xref>). The transfer of cancer cell-derived mitochondria to CD8<sup>+</sup> T cells causes endogenous mitochondria to accumulate mtDNA mutations and undergo mitophagy, while the cancer cell-derived mitochondria remain intact due to cotransfer of the deubiquitinase USP30 [<xref rid="R131" ref-type="bibr">131</xref>]. Conversely, transplantation of healthy mitochondria from young fibroblasts into aged CD4<sup>+</sup> T cells reduces senescence by improving metabolic fitness, resulting in increased control of <italic toggle="yes">Mycobacterium tuberculosis</italic> or influenza A upon adoptive transfer into mice [<xref rid="R132" ref-type="bibr">132</xref>,<xref rid="R133" ref-type="bibr">133</xref><bold>]</bold>. Mechanistically, mitochondrial transfer from mesenchymal stem/stromal cells (MSCs) enhances the apoptotic resistance of both native and engineered T cells by maintaining mitochondrial fitness and increasing cellular expression of antiapoptotic protein Bcl2 [<xref rid="R134" ref-type="bibr">134</xref>]. Beyond the contexts of cancer or infectious disease, organelle transfer may serve as a regulatory mechanism for controlling autoimmune or inflammatory responses, as mitochondrial transfer from MSCs to CD4<sup>+</sup> T cells increases the accumulation of Foxp3<sup>+</sup> Tregs [<xref rid="R135" ref-type="bibr">135</xref><bold>]</bold>. While lysosomal transfer between T cells and other cell types has not been described, the functional effects would likely be similar to those observed with mitochondrial transfer. Specifically, transfer of functional lysosomes may enhance nutrient sensing and recycling, while transfer of dysfunctional lysosomes may compromise T cell metabolism and functional fitness. How intercellular organelle transfer beyond mitochondria shapes T cell immunometabolism will be important to explore.</p><fig position="anchor" id="F5" orientation="portrait"><label>Figure I.</label><caption><title>Mitochondrial transfer has donor cell-dependent effects on T cell function.</title><p id="P68">Upper: transfer of cancer cell-derived mitochondria to intratumoral T cells via TNTs induces metabolic dysfunction in T cells. Lower: isolation of healthy mitochondria from young fibroblasts and <italic toggle="yes">ex vivo</italic> transplantation into aged T cells promotes metabolic fitness and functional reinvigoration of aged T cells.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-2100613-f0005.jpg"/></fig></boxed-text></floats-group></article></pmc-articleset>